<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2024.1341599</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Role of protein Post-translational modifications in enterovirus infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhao</surname>
<given-names>Xiaohui</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2580921/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Yibo</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1330876/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1209816/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Xueman</given-names>
</name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1451857/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Hongru</given-names>
</name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xing</surname>
<given-names>Yonghua</given-names>
</name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Pathogen Biology, School of Medicine, Qinghai University</institution>, <addr-line>Qinghai</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Orthopaedic Trauma, The Affiliated Hospital of Qinghai University</institution>, <addr-line>Qinghai</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Immunology, School of Medicine</institution>, <addr-line>Qinghai</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Traditional Chinese Medicine, School of Medicine, Qinghai University</institution>, <addr-line>Qinghai</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Public Health, School of Medicine, Qinghai University</institution>, <addr-line>Qinghai</addr-line>, <country>China</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Genetics, School of Medicine, Qinghai University</institution>, <addr-line>Qinghai</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001"><p>Edited by: Leiliang Zhang, Shandong First Medical University and Shandong Academy of Medical Sciences, China</p></fn>
<fn fn-type="edited-by" id="fn0002"><p>Reviewed by: Girish Patil, Oklahoma State University, United States</p><p>Mir Mubashir Khalid, Gladstone Institutes, United States</p><p>Fuminori Tokunaga, Osaka Metropolitan University, Japan</p></fn>
<corresp id="c001">&#x002A;Correspondence: Xiaohui Zhao, <email>xiaohuizhao@qhu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1341599</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>11</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>01</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Zhao, Hu, Zhao, Liu, Ma, Chen and Xing.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Zhao, Hu, Zhao, Liu, Ma, Chen and Xing</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Enteroviruses (EVs) are the main cause of a number of neurological diseases. Growing evidence has revealed that successful infection with enteroviruses is highly dependent on the host machinery, therefore, host proteins play a pivotal role in viral infections. Both host and viral proteins can undergo post-translational modification (PTM) which can regulate protein activity, stability, solubility and interactions with other proteins; thereby influencing various biological processes, including cell metabolism, metabolic, signaling pathways, cell death, and cancer development. During viral infection, both host and viral proteins regulate the viral life cycle through various PTMs and different mechanisms, including the regulation of host cell entry, viral protein synthesis, genome replication, and the antiviral immune response. Therefore, protein PTMs play important roles in EV infections. Here, we review the role of various host- and virus-associated PTMs during enterovirus infection.</p>
</abstract>
<kwd-group>
<kwd>enterovirus infection</kwd>
<kwd>post-translation modification</kwd>
<kwd>host factors</kwd>
<kwd>pathogenesis</kwd>
<kwd>enterovirus life cycle</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="119"/>
<page-count count="13"/>
<word-count count="9484"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Virology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>Enterovirus infections caused by various pathogens, such as coxsackievirus B (CVB), poliovirus, and enterovirus 71 (EV71), can cause serious diseases (<xref ref-type="bibr" rid="ref5">Bauer et al., 2019</xref>; <xref ref-type="bibr" rid="ref75">Saguil et al., 2019</xref>). To achieve efficient infection, these viruses must co-opt the host cell machinery which is involved in the progression of every stage in the enterovirus life cycle (<xref ref-type="fig" rid="fig1">Figure 1</xref>) (<xref ref-type="bibr" rid="ref88">Tabor-Godwin et al., 2012</xref>; <xref ref-type="bibr" rid="ref60">Lyoo et al., 2017</xref>; <xref ref-type="bibr" rid="ref99">Wu and Chu, 2017</xref>). Post-translational modification (PTM) of proteins diversify proteome function by covalently adding small proteins or other groups, potentially altering their cellular localization, interaction with partners, and activation state (<xref ref-type="bibr" rid="ref76">Schweppe et al., 2003</xref>; <xref ref-type="bibr" rid="ref119">Zolg et al., 2018</xref>). The disruption of PTMs can upset normal physiological processes (<xref ref-type="bibr" rid="ref30">Gupta et al., 2021</xref>; <xref ref-type="bibr" rid="ref34">He et al., 2021</xref>; <xref ref-type="bibr" rid="ref83">Smith and Carregari, 2022</xref>). The rapid development of proteomics and mass spectrometry has identified an increasing number of PTMs, including glycosylation, ubiquitination, methylation, phosphorylation, acetylation, and lipidation (<xref ref-type="bibr" rid="ref3">Aslebagh et al., 2019</xref>; <xref ref-type="bibr" rid="ref1">Andres et al., 2020</xref>; <xref ref-type="bibr" rid="ref35">Hermann et al., 2022</xref>). The progression of PTMs is dynamic, reversible, and catalyzed by specific enzymes; therefore, many compounds targeting these enzymes can effectively inhibit or promote PTM (<xref ref-type="bibr" rid="ref58">Lopez et al., 2016</xref>; <xref ref-type="bibr" rid="ref86">Sun et al., 2020</xref>; <xref ref-type="bibr" rid="ref117">Zhu et al., 2022c</xref>). Different PTMs on different host and viral proteins can exert various effects on viral growth by targeting viral entry, replication, assembly, egress, and antiviral immune response (<xref ref-type="bibr" rid="ref49">Kumar et al., 2020</xref>; <xref ref-type="bibr" rid="ref85">Song et al., 2021</xref>; <xref ref-type="bibr" rid="ref14">Cheng et al., 2022</xref>; <xref ref-type="bibr" rid="ref102">Xue et al., 2022</xref>). Here, we review some essential PTMs, including ubiquitination, phosphorylation, acetylation, SUMOylation, tyrosine sulfation, neddylation, and ISGylation, associated with host-pathogen interactions to better understand the role and mechanism of PTMs during enterovirus infection.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>The enterovirus life cycle depends heavily on diverse host machinery. Step 1. Entry: The three main steps by which EV71 virus particles enter the host cell are adhesion onto the host cell surface, binding of viral particles to cell receptors, and entry of viral particles into cells through endocytic pathways. Step 2. Uncoating and genome release: under the influence of the pH environment of the host cell, the virus sheds its shell and releases its genome. Step 3. Translation and cleavage of viral polyprotein: under the influence of various host proteins, translation of viral RNA is initiated and the resulting polyprotein is cleaved to obtain the structural and non-structural proteins. Step 4. Replication of viral genomes: viral genome replication requires the participation of a large number of host factors and viral proteins to complete the formation of replication organelles (ROs) and genome replication. Step 5. Assembly and release of viral particles: the assembly of viral particles also requires coordination between various viral and host proteins. After the assembly, the virus particles are released into the extracellular space in various ways to initiate the next round of infection.</p>
</caption>
<graphic xlink:href="fmicb-15-1341599-g001.tif"/>
</fig>
</sec>
<sec id="sec2">
<label>2</label>
<title>Ubiquitination</title>
<p>As a pivotal PTM, ubiquitination plays a role in various cellular processes in eukaryotes according to egiht differently-linked polyUb chains which established via conjugation to intrinsic ubiquitin residues, including seven Lys residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48 or Lys63) or the N-terminal Met1 residue (<xref ref-type="bibr" rid="ref11">Chau et al., 1989</xref>; <xref ref-type="bibr" rid="ref37">Hoege et al., 2002</xref>; <xref ref-type="bibr" rid="ref51">Lauwers et al., 2009</xref>). The differently-linked polyUb chains code for distinct signaling outcomes including cancer development, protein trafficking, cell death, immune response, signaling pathways, and viral infection, through its proteolytic and non-proteolytic functions (<xref ref-type="bibr" rid="ref48">Komander, 2009</xref>; <xref ref-type="bibr" rid="ref21">Dores and Trejo, 2014</xref>; <xref ref-type="bibr" rid="ref91">van Wijk et al., 2019</xref>; <xref ref-type="bibr" rid="ref40">Iwai, 2021</xref>; <xref ref-type="bibr" rid="ref70">Pellegrino et al., 2022</xref>; <xref ref-type="bibr" rid="ref67">Park et al., 2022a</xref>). This process is catalyzed by E1, E2, and E3 which enable ubiquitin (Desai et al.) and Ub-like modifiers, SUMO, NEDD8, and ISG15, to bind to substrate proteins, and is described as ubiquitination, SUMOylation, neddylation, and ISGylation, respectively (<xref ref-type="bibr" rid="ref44">Kang and Yi, 2011</xref>; <xref ref-type="bibr" rid="ref107">Zhang et al., 2017</xref>). These modifications play different roles in enterovirus infections.</p>
<sec id="sec3">
<label>2.1</label>
<title>The antiviral role of ubiquitination in enterovirus infection</title>
<p>Ubiquitination is widely involved in various physiological processes, and its dysregulation plays an important role in various diseases, including enterovirus infections (<xref ref-type="bibr" rid="ref87">Swatek and Komander, 2016</xref>; <xref ref-type="bibr" rid="ref73">Rape, 2018</xref>). Numerous studies have shown that protein ubiquitination can inhibit enterovirus infection through different mechanisms. An increasing number of studies have indicated that tripartite motif (TRIM) proteins, which have E3 Ub ligase activity, play pivotal roles in inhibiting viral infections including those caused by enteroviruses. A previous study revealed that TRIM7 inhibits enteroviral replication by ubiquitination and degradation of viral 2&#x2009;BC (Change &#x201C;2C&#x201D; into &#x201C;2&#x2009;BC&#x201D;) protein. Mechanistic studies have shown that TRIM7 recognizes the C-terminal region of 2C via the PRY-SPRY domain, thus mediating the degradation of the 2&#x2009;BC (Change &#x201C;2C&#x201D; into &#x201C;2&#x2009;BC&#x201D;) protein (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) (<xref ref-type="bibr" rid="ref22">Fan et al., 2021</xref>). Another study showed that the E3 Ub ligase TRIM38 disrupts EV71 infection by ubiquitinating cellular proteins that regulate immune signaling pathways or interact with viral proteins (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) (<xref ref-type="bibr" rid="ref55">Liu et al., 2011</xref>). In addition, TRIM proteins can suppress enterovirus infection by regulating the immune response through different mechanisms. TRIM21 can mediate the upregulation of type I interferon signaling by interacting with mitochondrial anti-viral signaling protein (MAVS), eventually catalyzing the K27-linked polyubiquitination of MAVS and inhibiting CVB3 infection (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) (<xref ref-type="bibr" rid="ref56">Liu et al., 2018</xref>). Enterovirus 3C proteins suppress retinoic acid-inducible gene I (RIG-I)-mediated type I interferon (IFN) responses via their cleavage activity, however, TRIM25 overexpression rescues this suppression. TRIM25 mediates the RIG-I ubiquitination and restores its expression and IFN-&#x03B2; production, indicating that TRIM25 can abolish enterovirus infection (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) (<xref ref-type="bibr" rid="ref100">Xiao et al., 2021</xref>). Arrestin domain containing 4 (ARRDC4) plays pivotal roles in G-protein-coupled receptor-associated physiological and pathological processes and glucose metabolism. A previous study reported that the expression of ARRDC4 was increased after EV71 infection, both <italic>in vitro</italic> and <italic>in vivo</italic>. Subsequently, ARRDC4 interacts with melanoma differentiation-associated protein 5 (MDA5) and recruits TRIM65 to increase K63-linked ubiquitination of MDA5 (Change &#x201C;TRIM65 to increase MDA5 K63 ubiquitination&#x201D; into &#x201C;TRIM65 to increase K63-linked ubiquitination of MDA5&#x201D;), eventually leading to the activation of the innate signaling pathway and inhibition of EV71 infection (<xref ref-type="fig" rid="fig2">Figure 2E</xref>) (<xref ref-type="bibr" rid="ref63">Meng et al., 2017</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>The antiviral role of ubiquitination in enterovirus infection. <bold>(A)</bold> TRIM7 recognizes the C-terminal region of 2C via the PRY-SPRY domain, thereby mediating degradation of the 2&#x2009;BC (Change 2C into 2&#x2009;BC) protein to inhibit enterovirus replication. <bold>(B)</bold> TRIM38 disrupts EV71 infection by ubiquitinating cellular proteins that regulate immune signaling pathways or their interactions with viral proteins. <bold>(C)</bold> TRIM21 mediates the enhancement of type I interferon signaling by interacting with mitochondrial anti-viral signaling protein to catalyze the K27-linked polyubiquitination of mitochondrial anti-viral signaling protein, which inhibits CVB3 infection. <bold>(D)</bold> TRIM25 mediates RIG-I ubiquitination and restores RIG-I expression and IFN-&#x03B2; production to prevent enterovirus infection. <bold>(E)</bold> EV71 infection induces ARRDC4 expression Subsequently, ARRDC4 interacts with MDA5 and recruits TRIM65 to increase MDA5 K63 ubiquitination, leading to the activation of the innate signaling pathway; thus, inhibiting EV71 infection.</p>
</caption>
<graphic xlink:href="fmicb-15-1341599-g002.tif"/>
</fig>
<p>The Ub-proteasome system (UPS) can also inhibit enterovirus infection through other mechanisms. The internal ribosome entry site (IRES) is an EV71 genomic functional element that is essential for the translation of viral proteins. Kung YA et al. reported that the negative IRES trans-acting factor KH-type splicing regulatory protein (KHSRP) downregulates IRES-mediated translation in enterovirus-infected cells by interacting with KLHL12, a substrate adaptor for the E3 ligase complex; leading to KHSRP ubiquitination (<xref ref-type="table" rid="tab1">Table 1</xref>) (<xref ref-type="bibr" rid="ref50">Kung et al., 2017</xref>). Many chemical compounds can also participate in the UPS to regulate enterovirus infections. Curcumin (diferuloylmethane) is a natural polyphenolic compound that dysregulates the UPS. Si X et al. found that curcumin treatment markedly decreases the replication of coxsackieviruses. Further investigation revealed that not only 20S proteasome proteolytic activities but also cellular deubiquitination activities were decreased after curcumin treatment, which led to the accumulation of ubiquitinated proteins and a reduction of free ubiquitin (Change &#x201C;ubiquitinated protein&#x201D; into &#x201C;ubiquitin&#x201D;) (<xref ref-type="table" rid="tab1">Table 1</xref>) (<xref ref-type="bibr" rid="ref82">Si et al., 2007</xref>). Pyrrolidine dithiocarbamate (PDTC) is an antioxidant that suppresses ubiquitin proteasome-mediated proteolysis. A previous study reported that the synthesis of CVB3 viral RNA, expression of viral protein VP1, and the release of viral progeny were significantly reduced after PDTC treatment. Further evidence indicated that the negative effect of PDTC on viral infection is probably related to the regulation of ubiquitination (<xref ref-type="table" rid="tab1">Table 1</xref>) (<xref ref-type="bibr" rid="ref81">Si et al., 2005b</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>The anti-enterovirus role of other proteins and chemical compounds involved in ubiquitin-proteasome system (UPS).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Proteins and compounds</th>
<th align="left" valign="top">Mechanisms</th>
<th align="left" valign="top">Effect</th>
<th align="left" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">KHSRP</td>
<td align="left" valign="middle">KHSRP ubiquitination</td>
<td align="left" valign="middle">Downregulate the IRES-mediated translation in enterovirus infected cells</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref50">Kung et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Curcumin</td>
<td align="left" valign="middle">Enhanced accumulation of ubiquitinated proteins</td>
<td align="left" valign="middle">Decreased the replication of coxsackievirus</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref82">Si et al. (2007)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">PDTC (Pyrrolidine dithiocarbamate)</td>
<td align="left" valign="middle">Regulation of ubiquitination</td>
<td align="left" valign="middle">Reduced CVB3 infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref81">Si et al. (2005b)</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>The negative IRES trans-acting factor KHSRP and the chemical compounds curcumin and pyrrolidine dithiocarbamate participate in the UPS to inhibit enterovirus infection.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>The proviral role of ubiquitination in enterovirus infection</title>
<p>The ubiquitination of proteins can also play a positive role in enterovirus infection. siRNA-mediated downregulation of Ub can decrease CVB3 infection by downregulating the ubiquitination and degradation of proteins. Furthermore, the 3D protein of CVB3 is modified by ubiquitination, and this ubiquitination is required for efficient viral replication (<xref ref-type="table" rid="tab2">Table 2</xref>) (<xref ref-type="bibr" rid="ref79">Si et al., 2008</xref>). Additionally, Voss M et al. showed that during CVB3 infection, there is an increase of ubiquitinated (Change &#x201C;ubiquitinylated&#x201D; into &#x201C;ubiquitinated&#x201D;) proteins in virus-utilized membranes that direct proteins to proteasomal degradation. This process is exploited by CVB3 for the cleavage of viral polyprotein fragments P1 and P3 to ensure correct viral replication (<xref ref-type="table" rid="tab2">Table 2</xref>) (<xref ref-type="bibr" rid="ref93">Voss et al., 2021</xref>). The host cell cycle regulatory machinery can also be modified by CVB3 to promote viral replication. To create a favorable environment for CVB3 replication, CVB3 infection can disrupt the homeostasis of host cells by increasing the ubiquitin-dependent proteolysis of cyclin D1, which results in cell cycle arrest (<xref ref-type="table" rid="tab2">Table 2</xref>) (<xref ref-type="bibr" rid="ref59">Luo et al., 2003</xref>). Cardiac failure is a serious complication of CVB3 infections. Intercalated disks (ICDs) are connections that sustain cardiac structures and mediate signal communication among cardiomyocytes, and ICD deficiency can lead to heart dysfunction. Ye X et al. revealed that CVB3-induced miR-21 expression could target the deubiquitinating enzyme YOD1 to increase K48-linked ubiquitination and degradation of desmin, a component of ICDs; resulting in the destruction of desmosomes and enhanced cardiomyocyte injury (<xref ref-type="table" rid="tab2">Table 2</xref>) (<xref ref-type="bibr" rid="ref104">Ye et al., 2014</xref>). During CVB3 infection, the expression levels of the UPS-related proteins E1A/E1B&#x3001;UBCH7 (Add&#x201C;UBCH7&#x201D;)and UCHL1 are significantly upregulated, indicating that the UPS plays a significant role in CVB3 infection (<xref ref-type="table" rid="tab2">Table 2</xref>) (<xref ref-type="bibr" rid="ref25">Gao et al., 2008</xref>).</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>The proteins and mechanisms involved in ubiquitination promote enterovirus infection.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Proteins and compounds</th>
<th align="left" valign="top">Mechanisms</th>
<th align="left" valign="top">Effect</th>
<th align="left" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">siRNA-mediated downreguiation of ubiquitin</td>
<td align="left" valign="middle">Downregulated the ubiquitination and degradation af proteins</td>
<td align="left" valign="middle">Decreased CVB3 infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref79">Si et al. (2008)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">CVB3 3D protein</td>
<td align="left" valign="middle">Modified by ubiquitination</td>
<td align="left" valign="middle">Benefit CVB3 replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref79">Si et al. (2008)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Prateins at virus-utilized membranes</td>
<td align="left" valign="middle">Processing of the viral polyprotein fragments P1 and P3</td>
<td align="left" valign="middle">Benefit CVB3 replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref93">Voss et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Cyclin D1</td>
<td align="left" valign="middle">Increasing ubiquitin-dependent proteolysis af cyclin D1</td>
<td align="left" valign="middle">Benefit CVB3 replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref59">Luo et al. (2003)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Desmin</td>
<td align="left" valign="middle">K48-linked ubiquitination and degradation of desmin</td>
<td align="left" valign="middle">Enhance the injury of CVB3-infected cardiomyocytes</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref104">Ye et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">E1A/E1B, UBCH7, UCHL1</td>
<td align="left" valign="middle">The expression level of E1A/E1BUBCH7 and UCHL1 enhanced</td>
<td align="left" valign="middle">Benefit CVB3 replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref25">Gao et al. (2008)</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>siRNA-mediated downregulation of ubiquitin, higher levels of ubiquitinated (Change &#x201C;ubiquitinylated&#x201D; into &#x201C;ubiquitinated&#x201D;) proteins, increased ubiquitin-dependent proteolysis of cyclin D1, YOD1-mediated increase in desmin K48-linked ubiquitination, and UPS-related proteins E1A/E1B and UCHL1 all play proviral roles during enterovirus infection through different mechanisms.</p>
</table-wrap-foot>
</table-wrap>
<p>Similarly, ubiquitination promotes enterovirus infection by regulating immune responses. SAM and HD Domain containing Deoxynucleoside Triphosphate Triphosphohydrolase 1 (SAMHD1) is an effector of innate immunity and has been confirmed as a restrictive factor for EV71. However, further studies have revealed that during EV71 infection, this inhibition can be overcome via ubiquitination of SAMHD1 by TRIM21 and its subsequently degradation through the proteasomal pathway (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) (<xref ref-type="bibr" rid="ref53">Li et al., 2020</xref>). Tumor necrosis factor receptor-associated factor 6 (TRAF6) is an important protein in the RIG-I-like receptor (RLR)-mediated antiviral signaling pathway that also regulates EV71 infection via a ubiquitination-associated pathway. RLR-induced NF-&#x03BA;B signaling is upregulated by ubiquitin-specific protease 4 (USP4)-mediated TRAF6 K48-linked deubiquitination, which ultimately suppresses EV71 replication (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) (<xref ref-type="bibr" rid="ref101">Xu et al., 2018</xref>). RNA interference (RNAi) is a conserved antiviral immune mechanism in various eukaryotes, and STIP1 homology and U-box containing protein 1 (STUB1) regulates the RNAi machinery in mammals. A previous study revealed that STUB1 interacts with Argonaute RISC Catalytic Component 2 (AGO2) and accelerates its K48-linked ubiquitination; thus facilitating its degradation, decreasing the RNAi response, and promoting EV71 replication in mammalian cells (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) (<xref ref-type="bibr" rid="ref111">Zhang et al., 2022</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>The proviral role of ubiquitination in enterovirus infection. <bold>(A)</bold> TRIM21-mediated ubiquitination of SAMHD1 leads to the degradation of SAMHD1, thus promoting EV71 infection. <bold>(B)</bold> USP4-mediated TRAF6 K48-linked deubiquitination induces the upregulation of RLR-induced NF-&#x03BA;B signaling to suppress the EV71 replication. <bold>(C)</bold> STUB1 interacts with AGO2 and accelerates the K48-linked ubiquitination of AGO2, thus promoting its degradation and decreasing the RNAi response; thereby promoting EV-71 replication.</p>
</caption>
<graphic xlink:href="fmicb-15-1341599-g003.tif"/>
</fig>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>The roles of Ub-like modification in enterovirus infection</title>
<p>Both of SUMO, NEDD8 and ISG15 are Ubiquitin-Like Proteins (<xref ref-type="bibr" rid="ref36">Herrmann et al., 2007</xref>). The SUMO proteins share structural similarities with ubiquitin, and the conjugation of SUMO proteins to substrates happens via a serious of enzymatic cascade involving the E1,E2 and E3 protein ligase. When a SUMO peptide tagged on the lysine residue of the protein substrate it could regulated various cellular processes, including transcription, replication, chromosome segregation and DNA repair (<xref ref-type="bibr" rid="ref27">Geiss-Friedlander and Melchior, 2007</xref>; <xref ref-type="bibr" rid="ref26">Gareau and Lima, 2010</xref>). NEDD8 is 60% identical and 80% homologous to ubiquitin. When NEDD8 tagged to the substrate protein, it regulated protein metabolism and activity (<xref ref-type="bibr" rid="ref7">Cappadocia and Lima, 2018</xref>). Interferon-Stimulated Gene 15 protein (ISG15) is expressed at low levels under physiological conditions (<xref ref-type="bibr" rid="ref19">Desai et al., 2006</xref>). Compared with ubiquitin, ISG15 shows substantial sequence variation from species to species. Once ISG15 is tagged to targets within the cell upon interferon stimulation, these cellular targets are involved in every aspect of cellular function, including DNA replication/repair, cell metabolism, signal transduction, and cytoskeletal organization and others (<xref ref-type="bibr" rid="ref64">Mirzalieva et al., 2022</xref>).</p>
<p>Viral proteins can be SUMOylated during the enterovirus life cycle. EV71 3C protein can be SUMO-modified by Ubc9, which decreases its protease activity and protein stability; thus decreasing EV71 replication (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) (<xref ref-type="bibr" rid="ref13">Chen et al., 2011</xref>). In addition, the 3D protein is modified by SUMO-1 during infection and combined with 3D ubiquitination, this can increase the stability of the 3D protein which promotes EV71 replication (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) (<xref ref-type="bibr" rid="ref57">Liu et al., 2016</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>The roles of Ub-like modification in enterovirus infection. <bold>(A)</bold> EV71 3C protein can be SUMO-modified by Ubc9 which decreases the protease activity and protein stability of 3C, thereby decreasing EV71 replication. <bold>(B)</bold> SUMOylation of the EV71 3D protein cooperates with 3D ubiquitination to increase its stability, eventually promoting the replication of EV71. <bold>(C)</bold> SUMOylation of REG&#x03B3; causes it to translocate from the nucleus to the cytoplasm, allowing the possible interaction of REG with viral or host proteins to play a proviral role during CVB3 infection. <bold>(D)</bold> The VP2 protein of EV71 is modified by NEDD8 at lysine 69, reducing its stability and decreasing viral replication. <bold>(E)</bold> Protein ISGylation blocks coxsackievirus pathology by increasing antiviral effectors, IFIT1/3 proteins, and metabolic reprogramming.</p>
</caption>
<graphic xlink:href="fmicb-15-1341599-g004.tif"/>
</fig>
<p>Host proteins can also be SUMOylated during viral infection. The SUMOylation of REG&#x03B3;, a component of the 11S proteasome activator, causes it to translocate from the nucleus to the cytoplasm, offering possibilities for the interaction of REG with viral or host proteins to play a proviral role during CVB3 infection (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) (<xref ref-type="bibr" rid="ref24">Gao et al., 2010</xref>). Neddylation also affects enterovirus infection. The VP2 protein of EV71 can be modified by NEDD8 at lysine 69, which reduces VP2 stability and decreases viral replication (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) (<xref ref-type="bibr" rid="ref96">Wang et al., 2022</xref>). Several studies have shown that protein modification with ISG15, referred to as ISGylation, plays a pivotal role in type I IFN-induced antimicrobial systems. One study revealed that ISGylation blocks coxsackievirus pathology by increasing the levels of antiviral effector IFIT1/3 proteins and metabolic reprogramming (<xref ref-type="fig" rid="fig4">Figure 4E</xref>) (<xref ref-type="bibr" rid="ref46">Kespohl et al., 2020</xref>).</p>
</sec>
</sec>
<sec id="sec6">
<label>3</label>
<title>Phosphorylation</title>
<p>Phosphorylation is a reversible process involving protein kinases and phosphatases which catalyze the phosphorylation of serine, threonine, and tyrosine in proteins. Protein phosphorylation plays a broad role in various biological events, including protein stability, protein interactions, transcription regulation, signal transduction, intracellular localization, and cell cycle progression (<xref ref-type="bibr" rid="ref112">Zhao et al., 2010</xref>; <xref ref-type="bibr" rid="ref109">Zhang and Pelech, 2012</xref>; <xref ref-type="bibr" rid="ref20">Deutscher et al., 2014</xref>; <xref ref-type="bibr" rid="ref71">Puertollano et al., 2018</xref>; <xref ref-type="bibr" rid="ref103">Yamasaki et al., 2020</xref>; <xref ref-type="bibr" rid="ref6">Bilbrough et al., 2022</xref>; <xref ref-type="bibr" rid="ref69">Park et al., 2022b</xref>). In addition, phosphorylation of both viral and cellular proteins can significantly affect enterovirus pathogenesis.</p>
<sec id="sec7">
<label>3.1</label>
<title>The antiviral role of phosphorylation in the infection of enterovirus</title>
<p>Currently, there are relatively few reports on inhibition of protein phosphorylation during enterovirus infection. One study revealed that the natural compound emodin, a natural compound derived from plant roots, can inhibit CVB3 replication by suppressing Akt/mTOR signaling and activating 4EBP1 and eEF2K (<xref ref-type="table" rid="tab3">Table 3</xref>) (<xref ref-type="bibr" rid="ref110">Zhang et al., 2016</xref>). Curcumin is a compound obtain anti-cancer properties that can decrease EV71 infection by inhibiting the phosphorylation of PKC&#x03B4; (<xref ref-type="table" rid="tab3">Table 3</xref>) (<xref ref-type="bibr" rid="ref39">Huang et al., 2018</xref>). Additionally, protein phosphorylation plays an antiviral role in enterovirus infection via an immune-regulated pathway. A study revealed that G3BP1 plays an anti-enterovirus role by inducing stress granule formation, and is associated with the innate immune transcriptional response activation through NF-&#x03BA;B and JNK (<xref ref-type="table" rid="tab3">Table 3</xref>) (<xref ref-type="bibr" rid="ref74">Reineke and Lloyd, 2015</xref>). Manassantin B inhibits CVB3 replication by activating the STING/TKB-1/IRF3 antiviral pathway and increasing the production of mROS (<xref ref-type="bibr" rid="ref84">Song et al., 2019</xref>). Cathelicidin antimicrobial peptides (human LL-37 and mouse CRAMP) (Add &#x201C;human LL-37 and mouse CRAMP&#x201D;) also play an antiviral role in EV71 infection and (Delete&#x201D;and&#x201D;) LL-37 and CRAMP were shown to markedly increase the basal IFN-&#x03B2; expression and IRF3 phosphorylation, effectively alleviating EV71 infection (<xref ref-type="bibr" rid="ref105">Yu et al., 2021</xref>). Trehalose prevents cardiovascular diseases by regulating autophagy. In a viral myocarditis mouse model induced by CVB3, trehalose was shown to reduce myocardial injury and significantly enhance AMPK and ULK1 phosphorylation in B cells (<xref ref-type="bibr" rid="ref97">Wei et al., 2022</xref>). During EV71 infection, STAT3 phosphorylation and the expression of downstream inflammatory regulators are increased, which activates the type I IFN-mediated antiviral response (<xref ref-type="bibr" rid="ref95">Wang et al., 2019</xref>). In addition, the host IKK&#x03B5; gene leads to alterations in IFN production during EV71 infection through phosphorylation and translocation of IRF7 in the presence of ubiquitin, activating the expression of IFN&#x03B2; and ISGs and attenuating viral propagation (<xref ref-type="table" rid="tab3">Table 3</xref>) (<xref ref-type="bibr" rid="ref10">Chang et al., 2021</xref>).</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>The antiviral role of phosphorylation in enterovirus infection.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Proteins and compounds</th>
<th align="left" valign="top">Mechanisms</th>
<th align="left" valign="top">Effect</th>
<th align="left" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Emodin</td>
<td align="left" valign="middle">Suppression Akt/mTOR signalling and activation 4EBP1 and eEF2K</td>
<td align="left" valign="middle">Suppress CVB3 replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref110">Zhang et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Curcumin</td>
<td align="left" valign="middle">The phosphorylation of PKC&#x03B4;</td>
<td align="left" valign="middle">Decrease EV71 infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref39">Huang et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">G3BP1</td>
<td align="left" valign="middle">Activation of innate immune transcriptional<break/>responses through NF-&#x03BA;B and JNK</td>
<td align="left" valign="middle">Against enteroviruses infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref74">Reineke and Lloyd (2015)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Manassantin B</td>
<td align="left" valign="middle">Activation of the STING/TBK-1/IRF3<break/>antiviral pathway</td>
<td align="left" valign="middle">Inhibit CVB3 replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref84">Song et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Cathelicidin</td>
<td align="left" valign="middle">increased the basal lFN-&#x03B2; expression<break/>and IRF3 phosphorylation</td>
<td align="left" valign="middle">Inhibit EV71 infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref105">Yu et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Trehalose</td>
<td align="left" valign="middle">Phosphorylation of AMPK and ULK1</td>
<td align="left" valign="middle">Reduce myocardial injury in CVB3-infected mice</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref97">Wei et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">STAT3</td>
<td align="left" valign="middle">STAT3 phosphorylation</td>
<td align="left" valign="middle">Inhibit EV71 intection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref95">Wang et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">IKK&#x03B5;</td>
<td align="left" valign="middle">Phosphorylation and translocation of IRF7</td>
<td align="left" valign="middle">Against EV71 infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref10">Chang et al. (2021)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec8">
<label>3.2</label>
<title>The proviral role of phosphorylation in enterovirus infection</title>
<p>Phosphorylation also plays an important role in the promotion of enterovirus infection. The cellular phosphoproteome undergoes significant changes and approximately 85% of the quantified phosphoproteome is dynamically regulated during CVB3 infection (<xref ref-type="bibr" rid="ref28">Giansanti et al., 2020</xref>). Once the EV71 virus binds to host receptors, the phosphorylation of PI3K/Akt and MAPK/ERK is initiated; immediately inactivating GSK3&#x03B2;, delaying host cell apoptosis, and promoting infection (<xref ref-type="bibr" rid="ref98">Wong et al., 2005</xref>). The IRE1/XBP1 pathway plays a pivotal role in the endoplasmic reticulum (ER), or unfolded protein, stress response. One study revealed that XBP1 participates in EV71 replication by affecting viral entry. After EV71 infection, IRE1 undergoes phosphorylation and activation, whereas the downstream XBP1s (spliced XBP1) protein levels decreased (<xref ref-type="bibr" rid="ref41">Jheng et al., 2012</xref>). During poliovirus and CVB3 infection, IRE1 undergoes the complicated dynamics of autophosphorylation and cleavage, indicating that enteroviruses utilize various mechanisms to regulate the Ire1-Xbp1 host defensive pathway in infected cells (<xref ref-type="bibr" rid="ref78">Shishova et al., 2022</xref>) (<xref ref-type="table" rid="tab4">Table 4</xref>).</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>The proviral role of phosphorylation in the infection of enterovirus.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Proteins and compounds</th>
<th align="left" valign="top">Mechanisms</th>
<th align="left" valign="top">Effect</th>
<th align="left" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">GSK3&#x03B2;</td>
<td align="left" valign="middle">Phospharylation of Pl3K/Akt<break/>and MAPK/ERK</td>
<td align="left" valign="middle">Promote EV71 infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref98">Wong et al. (2005)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">IRE1/XBP1</td>
<td align="left" valign="middle">The phosphorylation of IRE1</td>
<td align="left" valign="middle">Promote enteroviruses propagation</td>
<td align="left" valign="middle"><xref ref-type="bibr" rid="ref41">Jheng et al. (2012)</xref> and <xref ref-type="bibr" rid="ref78">Shishova et al. (2022)</xref></td>
</tr>
<tr>
<td align="left" valign="middle">PSF<break/>(PTB associated splicing factor)</td>
<td align="left" valign="middle">PSF phosphorytation</td>
<td align="left" valign="middle">Benefit CVB3 RNA translation</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref18">Dave et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">RASSF4</td>
<td align="left" valign="middle">Inhibit AKT phosphorylation</td>
<td align="left" valign="middle">Promote EV71 replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref108">Zhang et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Vimentin</td>
<td align="left" valign="middle">Vimentin phosphorylation and aggresomes formation</td>
<td align="left" valign="middle">Promote EV71 replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref32">Haolong et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">c10orf76</td>
<td align="left" valign="middle">Phosphorylation of PI4KB</td>
<td align="left" valign="middle">Promote enteroviruses replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref62">McPhail et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">GRP78/BiP</td>
<td align="left" valign="middle">Phosphorylation of PKR</td>
<td align="left" valign="middle">Promote EV71 replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref42">Jheng et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">EV71 3C protein</td>
<td align="left" valign="middle">PKR phosphorylation</td>
<td align="left" valign="middle">Promote EV71 replication</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref9">Chang et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Sam68</td>
<td align="left" valign="middle">PI3K/Akt activation</td>
<td align="left" valign="middle">Benefit EV71 infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref106">Zhang et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Protein Kinase C</td>
<td align="left" valign="middle">The localization of phosphorylated PKC</td>
<td align="left" valign="middle">Cell susceptibility to Echovirus1<break/>infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref90">Turkki et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Abl kinase</td>
<td align="left" valign="middle">Abl kinase activation</td>
<td align="left" valign="middle">Promote the CVBs entry and<break/>RNA release</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref15">Coyne and Bergelson (2006)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Fyn kinase</td>
<td align="left" valign="middle">Fyn kinase activation and phospharylation of caveolin</td>
<td align="left" valign="middle">Promote CVBs entry</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref15">Coyne and Bergelson (2006)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">SAPKs<break/>(Stress-activated prokein kinases)</td>
<td align="left" valign="middle">Phosphorylation of JNK1/2<break/>and p38 MAPK</td>
<td align="left" valign="middle">Promote CVB3 progeny release</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref80">Si et al. (2005a)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">HSF1</td>
<td align="left" valign="middle">HSF1 phosphorylation</td>
<td align="left" valign="middle">Stabilize the genome of CVB3</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref72">Qiu et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Vimentin</td>
<td align="left" valign="middle">Adivation of NLRP3 by<break/>VIM (Vimentin)-ERK-NF-&#x03BA;B pathway</td>
<td align="left" valign="middle">Benefit EV71 infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref29">Gong et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">SOCS proteins</td>
<td align="left" valign="middle">Inhibiting STAT3 phosphorylation</td>
<td align="left" valign="middle">Promote EV71 infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref23">Gao et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">EV71 2C Protein</td>
<td align="left" valign="middle">Suppressing lkk&#x03B2; phosphorylation</td>
<td align="left" valign="middle">Benefit EV71 infection</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref114">Zheng et al. (2011)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">Bosentan</td>
<td align="left" valign="middle">p38 MAPK phosphorylation</td>
<td align="left" valign="middle">Facilitate the progression of Caxsackievirus Induced Myecarditis</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref61">Marchant et al. (2009)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The phosphorylation of many proteins can regulate stages in the life cycle of enteroviruses. PTB associated splicing factor (PSF) is an IRES trans-acting factor which is critical for CVB3 RNA translation. One study revealed that PSF protein levels in the cytoplasm are enhanced during CVB3 infection and its phosphorylation promotes CVB3 RNA translation (<xref ref-type="bibr" rid="ref18">Dave et al., 2017</xref>). The tumor suppressor RASSF4, which participates in diverse biological processes including cell death, signal transduction, and tumor development, has been reported to promote EV71 infection and subsequently accelerate the inhibition of AKT phosphorylation in infected cells (<xref ref-type="bibr" rid="ref108">Zhang et al., 2015</xref>). The type III intermediate filament vimentin has been reported to be a key factor in the process of viral infection through different mechanisms. In EV71 infection of human astrocytoma cells, vimentin undergoes rearrangement immediately following the formation of aggresome-like structures in the perinuclear region. Further research has indicated that vimentin is phosphorylated, and that both phosphorylation and aggresome formation are important for EV71 replication (<xref ref-type="bibr" rid="ref32">Haolong et al., 2013</xref>) (<xref ref-type="table" rid="tab4">Table 4</xref>).</p>
<p>Enterovirus replication is heavily reliant on PI4KB kinase activity, and the interaction between PI4KB and c10orf76 is a critical Golgi signaling complex and an important factor influencing the replication of several enteroviruses. The affinity between PI4KB and c10orf76 is determined by the phosphorylation status of PI4KB, and the phosphorylated PI4KB at Ser496 site shows a decrease in affinity for c10orf76 (<xref ref-type="bibr" rid="ref62">McPhail et al., 2020</xref>). Enteroviruses can also use ER stress or the unfolded protein response to promote viral replication. Jheng JR et al. revealed that ER stress and the unfolded protein response, GRP78/BiP, were redistributed during EV71 infection, which contributed to the promotion of EV71 replication. Further studies showed that dsRNA, rather than a viral protein, induces the phosphorylation of PKR, which plays a role in GRP78/BiP redistribution (<xref ref-type="bibr" rid="ref42">Jheng et al., 2016</xref>). However, another study showed that in addition to dsRNA, viral proteins can also cause PKR phosphorylation, and that the EV71 3C protein interacts with PKR and subsequently mediates its phosphorylation to promote viral replication (<xref ref-type="bibr" rid="ref9">Chang et al., 2017</xref>) (<xref ref-type="table" rid="tab4">Table 4</xref>).</p>
<p>Numerous studies have shown that nuclear proteins translocate into the cytoplasm to promote EV71 replication. During EV71 infection, Sam68 translocates to the cytoplasm and mediates the activation of PI3K/Akt to assist the infection (<xref ref-type="bibr" rid="ref106">Zhang et al., 2014</xref>). The localization of phosphorylated host proteins is related to the susceptibility to viral infections. In a study of cell susceptibility to Echovirus1, phosphorylated PKC (Change &#x201C;pPKC&#x201D; into &#x201C;phosphorylated PKC&#x201D;) was mainly distributed in the cytoplasm and usually accumulated in the perinuclear compartment in non-permissive cells, whereas in permissive cells, it was evenly distributed and no perinuclear aggregation was observed (<xref ref-type="bibr" rid="ref90">Turkki et al., 2013</xref>) (<xref ref-type="table" rid="tab4">Table 4</xref>).</p>
<p>The activation of some kinases also plays a significant role in EV71 infection. The process of virus attachment to decay-accelerating factor on the surface of apical cells activates Abl kinase, which promotes the movement of the virus to tight junctions where it immediately interacts with coxsackievirus-adenovirus receptor, facilitating the alteration of conformation in the viral capsid. This process is critical for entry and RNA release. Additionally, interaction with decay-accelerating factor can activate Fyn kinase, which is necessary for caveolin phosphorylation and viral transportation into cells (<xref ref-type="bibr" rid="ref15">Coyne and Bergelson, 2006</xref>). Another study reported that the phosphorylation of JNK1/2 and p38 MAPK was enhanced during CVB3 infection and that the stress-activated protein kinase pathway plays a critical role in the life cycle of CVB3, especially during viral progeny release (<xref ref-type="bibr" rid="ref80">Si et al., 2005a</xref>). CVB3 infection induces phosphorylation of heat shock factor 1, leading to the upregulation of Hsp70-1 which contributes to the stabilization of the CVB3 genome; thus promoting viral infection (<xref ref-type="bibr" rid="ref72">Qiu et al., 2016</xref>) (<xref ref-type="table" rid="tab4">Table 4</xref>).</p>
<p>Phosphorylation also affects the host immune system, promoting EV infection, and the occurrence and development of enterovirus-related diseases. The inflammasome is an essential element of the natural immune system and is closely associated with EV71-induced central nervous system injury, which is regulated by signaling pathways such as VIM (Vimentin)-ERK-NF-&#x03BA;B pathway (Add &#x201C;Vimentin&#x201D;) (<xref ref-type="bibr" rid="ref29">Gong et al., 2022</xref>). Viruses can evade the host immune response by increasing the expression of suppressor of cytokine signaling proteins. One study revealed that suppressor of cytokine signaling 3 promotes EV71 infection by inhibiting interferon-induced STAT3 phosphorylation and negatively regulates the JAK/STAT signaling pathway; thus, allowing EV71 to escape host immunity (<xref ref-type="bibr" rid="ref23">Gao et al., 2020</xref>). Viral proteins also participate in immune responses related to phosphorylation. For example, EV71 2C protein inhibits TNF-&#x03B1;&#x2013;mediated activation of NF-&#x03BA;B by suppressing Ikk&#x03B2; phosphorylation (<xref ref-type="bibr" rid="ref114">Zheng et al., 2011</xref>).</p>
<p>In addition to endogenous cellular phosphorylation, chemical drugs increase the phosphorylation of cellular proteins to regulate viral infections. The endothelin-1 receptor antagonist Bosentan can facilitate the progression of Coxsackievirus-induced myocarditis by inducing p38 MAPK phosphorylation, which increases the viral load in cells and tissues (<xref ref-type="bibr" rid="ref61">Marchant et al., 2009</xref>) (<xref ref-type="table" rid="tab4">Table 4</xref>).</p>
</sec>
</sec>
<sec id="sec9">
<label>4</label>
<title>Acetylation</title>
<p>Protein acetylation is the principal PTM catalyzed by acetyltransferases (<xref ref-type="bibr" rid="ref4">Baeza et al., 2016</xref>). Protein acetylation affects numerous biological events, including gene replication, transcription, repair, and signal transduction pathways; thereby regulating diverse cellular processes (<xref ref-type="bibr" rid="ref2">Arnesen, 2011</xref>; <xref ref-type="bibr" rid="ref92">Verdin and Ott, 2015</xref>). Host and viral proteins undergo acetylation which can play pivotal roles in different phases of viral infection, including viral entry, genome replication, assembly and release of progeny viral particles, and host antiviral responses (<xref ref-type="bibr" rid="ref66">Murray et al., 2018</xref>; <xref ref-type="bibr" rid="ref102">Xue et al., 2022</xref>). With the rapid development and optimization of proteomics and mass spectrometry technologies, a new era of protein acetylation research during viral infection has recently emerged.</p>
<sec id="sec10">
<label>4.1</label>
<title>The antiviral role of acetylation in the infection of enterovirus</title>
<p>Sirtuin 1 (SIRT1) is a lysine deacetylase that regulates various processes including inflammation, metabolism, and aging. Han Y et al. revealed that reactive oxygen species generation and SIRT1 expression were downregulated in apoptotic cells infected with EV71, and treatment with a reactive oxygen species inhibitor decreased EV71 propagation and increased SIRT1 expression in EV71-infected cells. SIRT1 can inhibit the acetylation and RNA dependent RNA polymerase activity of 3D pol, thereby decreasing viral genome replication. Additionally, SIRT1 can interact with the 5&#x2032; UTR of EV71 RNA to disrupt viral RNA translation (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) (<xref ref-type="bibr" rid="ref31">Han et al., 2016</xref>). CVB3 infection induces HDAC2 activity and treatment with a HDAC inhibitor can inhibit CVB3 replication, indicating that the acetylation of proteins can suppress viral infection (<xref ref-type="fig" rid="fig5">Figure 5B</xref>) (<xref ref-type="bibr" rid="ref77">Shim et al., 2013</xref>). There are relatively few studies on inhibition of enterovirus infection by acetylation and further research is required to fully understand this process.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>The roles of acetylation in the infection of enterovirus. <bold>(A)</bold> SIRT1 can inhibit the acetylation and RNA dependent RNA polymerase activity of 3D pol, thus reducing viral genome replication. SIRT1 also interacts with the 5&#x2032; UTR of EV71 RNA to disrupt viral RNA translation. <bold>(B)</bold> CVB3 infection induces histone deacetylase2 (HDAC2) activity, and treatment with HDAC inhibitors can inhibit CVB3 replication. <bold>(C)</bold> Inhibition of HDAC activity increases the formation of autophagosomes which promote CVB3 replication and ultimately exacerbate the severity of CVB3-induced myocarditis. <bold>(D)</bold> CVB3 infection induces the expression of HDAC1 and Bax while suppressing SIRT1 and Bcl-2, in addition to upregulating acetylated p53. <bold>(E)</bold> NAT8 promotes EV71 replication by increasing the stability of 2B, 3AB, and 3C proteins in an acetyltransferase-activity-dependent manner.</p>
</caption>
<graphic xlink:href="fmicb-15-1341599-g005.tif"/>
</fig>
</sec>
<sec id="sec11">
<label>4.2</label>
<title>The proviral role of acetylation in enterovirus infection</title>
<p>Contrary to the results above, Zhou L et al. revealed that inhibition of HDAC can increase autophagosome formation, which benefits CVB3 replication and ultimately exacerbates the severity of CVB3-induced myocarditis (<xref ref-type="fig" rid="fig5">Figure 5C</xref>) (<xref ref-type="bibr" rid="ref115">Zhou et al., 2015</xref>). In addition to promoting viral infections, acetylation is related to the pathogenesis of viral myocarditis. CVB3 infection has been reported to induce the expression of HDAC1 and Bax while suppressing SIRT1 and Bcl-2 and upregulating acetylated p53. These events lead to cardiomyocyte apoptosis, thus promoting viral myocarditis progression (<xref ref-type="fig" rid="fig5">Figure 5D</xref>) (<xref ref-type="bibr" rid="ref43">Jiang et al., 2019</xref>). NAT8 is an ER-resident acetyltransferase and promotes EV71 replication by increasing the stability of 2B, 3AB, and 3C proteins in an acetyltransferase activity-dependent manner (<xref ref-type="fig" rid="fig5">Figure 5E</xref>) (<xref ref-type="bibr" rid="ref113">Zhao et al., 2022</xref>).</p>
</sec>
</sec>
<sec sec-type="conclusions" id="sec12">
<label>5</label>
<title>Conclusion</title>
<p>PTM of proteins is involved in various biological events, and disruption of the modification process can lead to the development of diseases (<xref ref-type="bibr" rid="ref12">Chaugule and Walden, 2016</xref>; <xref ref-type="bibr" rid="ref8">Caruso Bavisotto et al., 2020</xref>; <xref ref-type="bibr" rid="ref65">Morales-Tarre et al., 2021</xref>; <xref ref-type="bibr" rid="ref116">Zhu et al., 2022b</xref>). PTM participates in diverse viral infections, including hepatitis B, influenza, SARS-CoV-2, and enterovirus (<xref ref-type="bibr" rid="ref45">Karim et al., 2020</xref>; <xref ref-type="bibr" rid="ref38">Hofmann et al., 2023</xref>; <xref ref-type="bibr" rid="ref54">Liang et al., 2023</xref>; <xref ref-type="bibr" rid="ref68">Park et al., 2023</xref>). Currently, over 200 distinct covalent modifications have been reported; with phosphorylation, ubiquitination, acetylation, glycosylation being among the most common (<xref ref-type="bibr" rid="ref89">Tsikas, 2021</xref>). A growing body of work suggests that different PTMs play pro- or antiviral roles through different mechanisms, such as altering the abundance and biochemical properties of host and viral proteins, reducing proteins/protein or proteins/nucleic acid interaction, and regulating innate and adaptive immune responses. Although many studies have confirmed the roles of PTMs in viral infection, the understanding of PTMs has been limited by traditional approaches, owing to the difficulties in detection and complexity of these modifications (<xref ref-type="bibr" rid="ref17">Dai et al., 2021</xref>; <xref ref-type="bibr" rid="ref118">Zhu et al., 2022a</xref>). Traditionally, researchers utilize antibody-based assays to reveal specific PTMs; however, this detection approach fails to confirm the combinatorial patterns of diverse PTMs, and the antibodies have difficulty distinguishing specific modification sites (<xref ref-type="bibr" rid="ref33">Hattori and Koide, 2018</xref>; <xref ref-type="bibr" rid="ref52">Leutert et al., 2021</xref>). In recent years, increasing evidence of crosstalk between PTMs also has been reported (<xref ref-type="bibr" rid="ref16">Cuijpers and Vertegaal, 2018</xref>; <xref ref-type="bibr" rid="ref94">Vu et al., 2018</xref>; <xref ref-type="bibr" rid="ref47">Kirsch et al., 2020</xref>; <xref ref-type="bibr" rid="ref52">Leutert et al., 2021</xref>). Therefore, further in-depth investigation of the role and mechanisms of PTM crosstalk and other modifications in enterovirus infection is required.</p>
</sec>
<sec sec-type="author-contributions" id="sec13">
<title>Author contributions</title>
<p>XZ: Writing &#x2013; original draft, Investigation, Software, Supervision, Writing &#x2013; review &#x0026; editing. YH: Writing &#x2013; original draft. JZ: Writing &#x2013; original draft. YL: Writing &#x2013; original draft. XM: Writing &#x2013; review &#x0026; editing. HC: Writing &#x2013; review &#x0026; editing. YX: Writing &#x2013; review &#x0026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec14">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="sec15">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname> <given-names>M.</given-names></name> <name><surname>Garcia-Gomis</surname> <given-names>D.</given-names></name> <name><surname>Ponte</surname> <given-names>I.</given-names></name> <name><surname>Suau</surname> <given-names>P.</given-names></name> <name><surname>Roque</surname> <given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Histone H1 Post-translational modifications: update and future perspectives</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume>:<fpage>5941</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms21165941</pub-id>, PMID: <pub-id pub-id-type="pmid">32824860</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnesen</surname> <given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Towards a functional understanding of protein N-terminal acetylation</article-title>. <source>PLoS Biol.</source> <volume>9</volume>:<fpage>e1001074</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pbio.1001074</pub-id>, PMID: <pub-id pub-id-type="pmid">21655309</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aslebagh</surname> <given-names>R.</given-names></name> <name><surname>Wormwood</surname> <given-names>K. L.</given-names></name> <name><surname>Channaveerappa</surname> <given-names>D.</given-names></name> <name><surname>Wetie</surname> <given-names>A. G. N.</given-names></name> <name><surname>Woods</surname> <given-names>A. G.</given-names></name> <name><surname>Darie</surname> <given-names>C. C.</given-names></name></person-group> (<year>2019</year>). <article-title>Identification of posttranslational modifications (Ptms) of proteins by mass spectrometry</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>1140</volume>, <fpage>199</fpage>&#x2013;<lpage>224</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-3-030-15950-4_11</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baeza</surname> <given-names>J.</given-names></name> <name><surname>Smallegan</surname> <given-names>M. J.</given-names></name> <name><surname>Denu</surname> <given-names>J. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Mechanisms and dynamics of protein acetylation in mitochondria</article-title>. <source>Trends Biochem. Sci.</source> <volume>41</volume>, <fpage>231</fpage>&#x2013;<lpage>244</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tibs.2015.12.006</pub-id>, PMID: <pub-id pub-id-type="pmid">26822488</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname> <given-names>L.</given-names></name> <name><surname>Manganaro</surname> <given-names>R.</given-names></name> <name><surname>Zonsics</surname> <given-names>B.</given-names></name> <name><surname>Strating</surname> <given-names>J.</given-names></name> <name><surname>El Kazzi</surname> <given-names>P.</given-names></name> <name><surname>Lorenzo Lopez</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Fluoxetine inhibits enterovirus replication by targeting the viral 2C protein in a stereospecific manner</article-title>. <source>Acs Infect Dis</source> <volume>5</volume>, <fpage>1609</fpage>&#x2013;<lpage>1623</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acsinfecdis.9b00179</pub-id>, PMID: <pub-id pub-id-type="pmid">31305993</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bilbrough</surname> <given-names>T.</given-names></name> <name><surname>Piemontese</surname> <given-names>E.</given-names></name> <name><surname>Seitz</surname> <given-names>O.</given-names></name></person-group> (<year>2022</year>). <article-title>Dissecting the role of protein phosphorylation: a chemical biology toolbox</article-title>. <source>Chem. Soc. Rev.</source> <volume>51</volume>, <fpage>5691</fpage>&#x2013;<lpage>5730</lpage>. doi: <pub-id pub-id-type="doi">10.1039/D1CS00991E</pub-id>, PMID: <pub-id pub-id-type="pmid">35726784</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cappadocia</surname> <given-names>L.</given-names></name> <name><surname>Lima</surname> <given-names>C. D.</given-names></name></person-group> (<year>2018</year>). <article-title>Ubiquitin-like protein conjugation: structures, chemistry, and mechanism</article-title>. <source>Chem. Rev.</source> <volume>118</volume>, <fpage>889</fpage>&#x2013;<lpage>918</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00737</pub-id>, PMID: <pub-id pub-id-type="pmid">28234446</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caruso Bavisotto</surname> <given-names>C.</given-names></name> <name><surname>Alberti</surname> <given-names>G.</given-names></name> <name><surname>Vitale</surname> <given-names>A. M.</given-names></name> <name><surname>Paladino</surname> <given-names>L.</given-names></name> <name><surname>Campanella</surname> <given-names>C.</given-names></name> <name><surname>Rappa</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Hsp60 Post-translational modifications: functional and pathological consequences</article-title>. <source>Front. Mol. Biosci.</source> <volume>7</volume>:<fpage>95</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmolb.2020.00095</pub-id>, PMID: <pub-id pub-id-type="pmid">32582761</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>Y. H.</given-names></name> <name><surname>Lau</surname> <given-names>K. S.</given-names></name> <name><surname>Kuo</surname> <given-names>R. L.</given-names></name> <name><surname>Horng</surname> <given-names>J. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Dsrna binding domain of Pkr is Proteolytically released by enterovirus A71 to facilitate viral replication</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>7</volume>:<fpage>284</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2017.00284</pub-id>, PMID: <pub-id pub-id-type="pmid">28702377</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>Y. L.</given-names></name> <name><surname>Liao</surname> <given-names>Y. W.</given-names></name> <name><surname>Chen</surname> <given-names>M. H.</given-names></name> <name><surname>Chang</surname> <given-names>S. Y.</given-names></name> <name><surname>Huang</surname> <given-names>Y. T.</given-names></name> <name><surname>Ho</surname> <given-names>B. C.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Ikkepsilon isoform switching governs the immune response against Ev71 infection</article-title>. <source>Commun Biol</source> <volume>4</volume>:<fpage>663</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s42003-021-02187-x</pub-id>, PMID: <pub-id pub-id-type="pmid">34079066</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chau</surname> <given-names>V.</given-names></name> <name><surname>Tobias</surname> <given-names>J. W.</given-names></name> <name><surname>Bachmair</surname> <given-names>A.</given-names></name> <name><surname>Marriott</surname> <given-names>D.</given-names></name> <name><surname>Ecker</surname> <given-names>D. J.</given-names></name> <name><surname>Gonda</surname> <given-names>D. K.</given-names></name> <etal/></person-group>. (<year>1989</year>). <article-title>A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein</article-title>. <source>Science</source> <volume>243</volume>, <fpage>1576</fpage>&#x2013;<lpage>1583</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.2538923</pub-id>, PMID: <pub-id pub-id-type="pmid">2538923</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaugule</surname> <given-names>V. K.</given-names></name> <name><surname>Walden</surname> <given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Specificity and disease in the ubiquitin system</article-title>. <source>Biochem. Soc. Trans.</source> <volume>44</volume>, <fpage>212</fpage>&#x2013;<lpage>227</lpage>. doi: <pub-id pub-id-type="doi">10.1042/BST20150209</pub-id>, PMID: <pub-id pub-id-type="pmid">26862208</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>S. C.</given-names></name> <name><surname>Chang</surname> <given-names>L. Y.</given-names></name> <name><surname>Wang</surname> <given-names>Y. W.</given-names></name> <name><surname>Chen</surname> <given-names>Y. C.</given-names></name> <name><surname>Weng</surname> <given-names>K. F.</given-names></name> <name><surname>Shih</surname> <given-names>S. R.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume>, <fpage>31373</fpage>&#x2013;<lpage>31384</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M111.254896</pub-id>, PMID: <pub-id pub-id-type="pmid">21784861</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>N.</given-names></name> <name><surname>Liu</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Sun</surname> <given-names>B.</given-names></name> <name><surname>Liu</surname> <given-names>D.</given-names></name> <name><surname>Wang</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Protein post-translational modification in Sars-CoV-2 and host interaction</article-title>. <source>Front. Immunol.</source> <volume>13</volume>:<fpage>1068449</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.1068449</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coyne</surname> <given-names>C. B.</given-names></name> <name><surname>Bergelson</surname> <given-names>J. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions</article-title>. <source>Cell</source> <volume>124</volume>, <fpage>119</fpage>&#x2013;<lpage>131</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2005.10.035</pub-id>, PMID: <pub-id pub-id-type="pmid">16413486</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname> <given-names>S. A. G.</given-names></name> <name><surname>Vertegaal</surname> <given-names>A. C. O.</given-names></name></person-group> (<year>2018</year>). <article-title>Guiding mitotic progression by crosstalk between Post-translational modifications</article-title>. <source>Trends Biochem. Sci.</source> <volume>43</volume>, <fpage>251</fpage>&#x2013;<lpage>268</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tibs.2018.02.004</pub-id>, PMID: <pub-id pub-id-type="pmid">29486978</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname> <given-names>J.</given-names></name> <name><surname>Yu</surname> <given-names>F.</given-names></name> <name><surname>Zhou</surname> <given-names>C.</given-names></name> <name><surname>Yu</surname> <given-names>W.</given-names></name></person-group> (<year>2021</year>). <article-title>Understanding the limit of open search in the identification of peptides with Post-translational modifications - a simulation-based study</article-title>. <source>IEEE/ACM Trans. Comput. Biol. Bioinform.</source> <volume>18</volume>, <fpage>2884</fpage>&#x2013;<lpage>2890</lpage>. doi: <pub-id pub-id-type="doi">10.1109/TCBB.2020.2991207</pub-id>, PMID: <pub-id pub-id-type="pmid">32356758</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dave</surname> <given-names>P.</given-names></name> <name><surname>George</surname> <given-names>B.</given-names></name> <name><surname>Sharma</surname> <given-names>D. K.</given-names></name> <name><surname>Das</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Polypyrimidine tract-binding protein (Ptb) and Ptb-associated splicing factor in Cvb3 infection: an Itaf for an Itaf</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume>, <fpage>9068</fpage>&#x2013;<lpage>9084</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkx519</pub-id>, PMID: <pub-id pub-id-type="pmid">28633417</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname> <given-names>S. D.</given-names></name> <name><surname>Haas</surname> <given-names>A. L.</given-names></name> <name><surname>Wood</surname> <given-names>L. M.</given-names></name> <name><surname>Tsai</surname> <given-names>Y. C.</given-names></name> <name><surname>Pestka</surname> <given-names>S.</given-names></name> <name><surname>Rubin</surname> <given-names>E. H.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Elevated expression of Isg15 in tumor cells interferes with the ubiquitin/26S proteasome pathway</article-title>. <source>Cancer Res.</source> <volume>66</volume>, <fpage>921</fpage>&#x2013;<lpage>928</lpage>. doi: <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-1123</pub-id>, PMID: <pub-id pub-id-type="pmid">16424026</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deutscher</surname> <given-names>J.</given-names></name> <name><surname>Ake</surname> <given-names>F. M.</given-names></name> <name><surname>Derkaoui</surname> <given-names>M.</given-names></name> <name><surname>Zebre</surname> <given-names>A. C.</given-names></name> <name><surname>Cao</surname> <given-names>T. N.</given-names></name> <name><surname>Bouraoui</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>The bacterial phosphoenolpyruvate:carbohydrate phosphotransferase system: regulation by protein phosphorylation and phosphorylation-dependent protein-protein interactions</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>78</volume>, <fpage>231</fpage>&#x2013;<lpage>256</lpage>. doi: <pub-id pub-id-type="doi">10.1128/MMBR.00001-14</pub-id>, PMID: <pub-id pub-id-type="pmid">24847021</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dores</surname> <given-names>M. R.</given-names></name> <name><surname>Trejo</surname> <given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Atypical regulation of G protein-coupled receptor intracellular trafficking by ubiquitination</article-title>. <source>Curr. Opin. Cell Biol.</source> <volume>27</volume>, <fpage>44</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ceb.2013.11.004</pub-id>, PMID: <pub-id pub-id-type="pmid">24680429</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>W.</given-names></name> <name><surname>Mar</surname> <given-names>K. B.</given-names></name> <name><surname>Sari</surname> <given-names>L.</given-names></name> <name><surname>Gaszek</surname> <given-names>I. K.</given-names></name> <name><surname>Cheng</surname> <given-names>Q.</given-names></name> <name><surname>Evers</surname> <given-names>B. M.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Trim7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity</article-title>. <source>Cell</source> <volume>184</volume>:<fpage>e17</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2021.04.047</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>W.</given-names></name> <name><surname>Hou</surname> <given-names>M.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>W.</given-names></name></person-group> (<year>2020</year>). <article-title>Induction of Socs expression by Ev71 infection promotes Ev71 replication</article-title>. <source>Biomed. Res. Int.</source> <volume>2020</volume>:<fpage>2430640</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2020/2430640</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>G.</given-names></name> <name><surname>Wong</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Mao</surname> <given-names>I.</given-names></name> <name><surname>Shravah</surname> <given-names>J.</given-names></name> <name><surname>Wu</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Proteasome activator Reggamma enhances coxsackieviral infection by facilitating p53 degradation</article-title>. <source>J. Virol.</source> <volume>84</volume>, <fpage>11056</fpage>&#x2013;<lpage>11066</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.00008-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20719955</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>G.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Si</surname> <given-names>X.</given-names></name> <name><surname>Wong</surname> <given-names>J.</given-names></name> <name><surname>Cheung</surname> <given-names>C.</given-names></name> <name><surname>Mcmanus</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice</article-title>. <source>Am. J. Physiol. Heart Circ. Physiol.</source> <volume>295</volume>, <fpage>H401</fpage>&#x2013;<lpage>H408</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpheart.00292.2008</pub-id>, PMID: <pub-id pub-id-type="pmid">18515649</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gareau</surname> <given-names>J. R.</given-names></name> <name><surname>Lima</surname> <given-names>C. D.</given-names></name></person-group> (<year>2010</year>). <article-title>The Sumo pathway: emerging mechanisms that shape specificity, conjugation and recognition</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>11</volume>, <fpage>861</fpage>&#x2013;<lpage>871</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrm3011</pub-id>, PMID: <pub-id pub-id-type="pmid">21102611</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geiss-Friedlander</surname> <given-names>R.</given-names></name> <name><surname>Melchior</surname> <given-names>F.</given-names></name></person-group> (<year>2007</year>). <article-title>Concepts in sumoylation: a decade on</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>8</volume>, <fpage>947</fpage>&#x2013;<lpage>956</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrm2293</pub-id>, PMID: <pub-id pub-id-type="pmid">18000527</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giansanti</surname> <given-names>P.</given-names></name> <name><surname>Strating</surname> <given-names>J.</given-names></name> <name><surname>Defourny</surname> <given-names>K. A. Y.</given-names></name> <name><surname>Cesonyte</surname> <given-names>I.</given-names></name> <name><surname>Bottino</surname> <given-names>A. M. S.</given-names></name> <name><surname>Post</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Dynamic remodelling of the human host cell proteome and phosphoproteome upon enterovirus infection</article-title>. <source>Nat. Commun.</source> <volume>11</volume>:<fpage>4332</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-18168-3</pub-id>, PMID: <pub-id pub-id-type="pmid">32859902</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>Z.</given-names></name> <name><surname>Gao</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>Q.</given-names></name> <name><surname>Lun</surname> <given-names>J.</given-names></name> <name><surname>Xiao</surname> <given-names>H.</given-names></name> <name><surname>Zhong</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Phosphorylation of Erk-dependent Nf-kappaB triggers Nlrp3 Inflammasome mediated by vimentin in Ev71-infected glioblastoma cells</article-title>. <source>Molecules</source> <volume>27</volume>:4190. doi: <pub-id pub-id-type="doi">10.3390/molecules27134190</pub-id>, PMID: <pub-id pub-id-type="pmid">35807435</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>R.</given-names></name> <name><surname>Sahu</surname> <given-names>M.</given-names></name> <name><surname>Srivastava</surname> <given-names>D.</given-names></name> <name><surname>Tiwari</surname> <given-names>S.</given-names></name> <name><surname>Ambasta</surname> <given-names>R. K.</given-names></name> <name><surname>Kumar</surname> <given-names>P.</given-names></name></person-group> (<year>2021</year>). <article-title>Post-translational modifications: regulators of neurodegenerative proteinopathies</article-title>. <source>Ageing Res. Rev.</source> <volume>68</volume>:<fpage>101336</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arr.2021.101336</pub-id>, PMID: <pub-id pub-id-type="pmid">33775891</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Cui</surname> <given-names>J.</given-names></name> <name><surname>Song</surname> <given-names>Y.</given-names></name> <name><surname>Luo</surname> <given-names>Z.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Sirt1 inhibits Ev71 genome replication and Rna translation by interfering with the viral polymerase and 5'utr Rna</article-title>. <source>J. Cell Sci.</source> <volume>129</volume>, <fpage>4534</fpage>&#x2013;<lpage>4547</lpage>. doi: <pub-id pub-id-type="doi">10.1242/jcs.193698</pub-id> PMID: <pub-id pub-id-type="pmid">27875274</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haolong</surname> <given-names>C.</given-names></name> <name><surname>Du</surname> <given-names>N.</given-names></name> <name><surname>Hongchao</surname> <given-names>T.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Wei</surname> <given-names>Z.</given-names></name> <name><surname>Hua</surname> <given-names>Z.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Enterovirus 71 Vp1 activates calmodulin-dependent protein kinase ii and results in the rearrangement of vimentin in human astrocyte cells</article-title>. <source>PLoS One</source> <volume>8</volume>:<fpage>e73900</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0073900</pub-id>, PMID: <pub-id pub-id-type="pmid">24073199</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname> <given-names>T.</given-names></name> <name><surname>Koide</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Next-generation antibodies for post-translational modifications</article-title>. <source>Curr. Opin. Struct. Biol.</source> <volume>51</volume>, <fpage>141</fpage>&#x2013;<lpage>148</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.sbi.2018.04.006</pub-id>, PMID: <pub-id pub-id-type="pmid">29753204</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>F.</given-names></name> <name><surname>Yung</surname> <given-names>K. K. L.</given-names></name> <name><surname>Zhang</surname> <given-names>S.</given-names></name> <name><surname>Qu</surname> <given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Effects of alpha-Synuclein-associated Post-translational modifications in Parkinson's disease</article-title>. <source>ACS Chem. Neurosci.</source> <volume>12</volume>, <fpage>1061</fpage>&#x2013;<lpage>1071</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acschemneuro.1c00028</pub-id>, PMID: <pub-id pub-id-type="pmid">33769791</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hermann</surname> <given-names>J.</given-names></name> <name><surname>Schurgers</surname> <given-names>L.</given-names></name> <name><surname>Jankowski</surname> <given-names>V.</given-names></name></person-group> (<year>2022</year>). <article-title>Identification and characterization of post-translational modifications: clinical implications</article-title>. <source>Mol. Asp. Med.</source> <volume>86</volume>:<fpage>101066</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mam.2022.101066</pub-id>, PMID: <pub-id pub-id-type="pmid">35033366</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herrmann</surname> <given-names>J.</given-names></name> <name><surname>Lerman</surname> <given-names>L. O.</given-names></name> <name><surname>Lerman</surname> <given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Ubiquitin and ubiquitin-like proteins in protein regulation</article-title>. <source>Circ. Res.</source> <volume>100</volume>, <fpage>1276</fpage>&#x2013;<lpage>1291</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.RES.0000264500.11888.f0</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoege</surname> <given-names>C.</given-names></name> <name><surname>Pfander</surname> <given-names>B.</given-names></name> <name><surname>Moldovan</surname> <given-names>G. L.</given-names></name> <name><surname>Pyrowolakis</surname> <given-names>G.</given-names></name> <name><surname>Jentsch</surname> <given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Rad6-dependent Dna repair is linked to modification of Pcna by ubiquitin and Sumo</article-title>. <source>Nature</source> <volume>419</volume>, <fpage>135</fpage>&#x2013;<lpage>141</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature00991</pub-id>, PMID: <pub-id pub-id-type="pmid">12226657</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname> <given-names>S.</given-names></name> <name><surname>Plank</surname> <given-names>V.</given-names></name> <name><surname>Groitl</surname> <given-names>P.</given-names></name> <name><surname>Skvorc</surname> <given-names>N.</given-names></name> <name><surname>Hofmann</surname> <given-names>K.</given-names></name> <name><surname>Luther</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Sumo modification of hepatitis B virus Core mediates nuclear entry, Promyelocytic leukemia nuclear body association, and efficient formation of covalently closed circular Dna</article-title>. <source>Microbiol Spectr</source> <volume>11</volume>:<fpage>e0044623</fpage>. doi: <pub-id pub-id-type="doi">10.1128/spectrum.00446-23</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>H. I.</given-names></name> <name><surname>Chio</surname> <given-names>C. C.</given-names></name> <name><surname>Lin</surname> <given-names>J. Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Inhibition of Ev71 by curcumin in intestinal epithelial cells</article-title>. <source>PLoS One</source> <volume>13</volume>:<fpage>e0191617</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0191617</pub-id>, PMID: <pub-id pub-id-type="pmid">29370243</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iwai</surname> <given-names>K.</given-names></name></person-group> (<year>2021</year>). <article-title>Discovery of linear ubiquitination, a crucial regulator for immune signaling and cell death</article-title>. <source>FEBS J.</source> <volume>288</volume>, <fpage>1060</fpage>&#x2013;<lpage>1069</lpage>. doi: <pub-id pub-id-type="doi">10.1111/febs.15471</pub-id>, PMID: <pub-id pub-id-type="pmid">32627388</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jheng</surname> <given-names>J. R.</given-names></name> <name><surname>Lin</surname> <given-names>C. Y.</given-names></name> <name><surname>Horng</surname> <given-names>J. T.</given-names></name> <name><surname>Lau</surname> <given-names>K. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Inhibition of enterovirus 71 entry by transcription factor Xbp1</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>420</volume>, <fpage>882</fpage>&#x2013;<lpage>887</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2012.03.094</pub-id>, PMID: <pub-id pub-id-type="pmid">22469468</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jheng</surname> <given-names>J. R.</given-names></name> <name><surname>Wang</surname> <given-names>S. C.</given-names></name> <name><surname>Jheng</surname> <given-names>C. R.</given-names></name> <name><surname>Horng</surname> <given-names>J. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Enterovirus 71 induces dsrna/Pkr-dependent cytoplasmic redistribution of Grp78/BiP to promote viral replication</article-title>. <source>Emerg Microbes Infect</source> <volume>5</volume>:<fpage>e23</fpage>. doi: <pub-id pub-id-type="doi">10.1038/emi.2016.20</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>D.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Yu</surname> <given-names>Y.</given-names></name> <name><surname>Shi</surname> <given-names>H.</given-names></name> <name><surname>Chen</surname> <given-names>R.</given-names></name></person-group> (<year>2019</year>). <article-title>Microrna-34a aggravates coxsackievirus B3-induced apoptosis of cardiomyocytes through the Sirt1-p53 pathway</article-title>. <source>J. Med. Virol.</source> <volume>91</volume>, <fpage>1643</fpage>&#x2013;<lpage>1651</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jmv.25482</pub-id>, PMID: <pub-id pub-id-type="pmid">30968966</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>C.</given-names></name> <name><surname>Yi</surname> <given-names>G. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Identification of ubiquitin/ubiquitin-like protein modification from tandem mass spectra with various Ptms</article-title>. <source>BMC Bioinform</source> <volume>12</volume>:<fpage>S8</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2105-12-S14-S8</pub-id>, PMID: <pub-id pub-id-type="pmid">22373085</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karim</surname> <given-names>M.</given-names></name> <name><surname>Biquand</surname> <given-names>E.</given-names></name> <name><surname>Declercq</surname> <given-names>M.</given-names></name> <name><surname>Jacob</surname> <given-names>Y.</given-names></name> <name><surname>Van Der Werf</surname> <given-names>S.</given-names></name> <name><surname>Demeret</surname> <given-names>C.</given-names></name></person-group> (<year>2020</year>). <article-title>Nonproteolytic K29-linked ubiquitination of the Pb2 replication protein of influenza a viruses by Proviral Cullin 4-based E3 ligases</article-title>. <source>MBio</source> <volume>11</volume>. doi: <pub-id pub-id-type="doi">10.1128/mBio.00305-20</pub-id>, PMID: <pub-id pub-id-type="pmid">32265326</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kespohl</surname> <given-names>M.</given-names></name> <name><surname>Bredow</surname> <given-names>C.</given-names></name> <name><surname>Klingel</surname> <given-names>K.</given-names></name> <name><surname>Voss</surname> <given-names>M.</given-names></name> <name><surname>Paeschke</surname> <given-names>A.</given-names></name> <name><surname>Zickler</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Protein modification with Isg15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming</article-title>. <source>Sci. Adv.</source> <volume>6</volume>:<fpage>eaay1109</fpage>. doi: <pub-id pub-id-type="doi">10.1126/sciadv.aay1109</pub-id>, PMID: <pub-id pub-id-type="pmid">32195343</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirsch</surname> <given-names>R.</given-names></name> <name><surname>Jensen</surname> <given-names>O. N.</given-names></name> <name><surname>Schwammle</surname> <given-names>V.</given-names></name></person-group> (<year>2020</year>). <article-title>Visualization of the dynamics of histone modifications and their crosstalk using Ptm-CrossTalkMapper</article-title>. <source>Methods</source> <volume>184</volume>, <fpage>78</fpage>&#x2013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ymeth.2020.01.012</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Komander</surname> <given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>The emerging complexity of protein ubiquitination</article-title>. <source>Biochem. Soc. Trans.</source> <volume>37</volume>, <fpage>937</fpage>&#x2013;<lpage>953</lpage>. doi: <pub-id pub-id-type="doi">10.1042/BST0370937</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>R.</given-names></name> <name><surname>Mehta</surname> <given-names>D.</given-names></name> <name><surname>Mishra</surname> <given-names>N.</given-names></name> <name><surname>Nayak</surname> <given-names>D.</given-names></name> <name><surname>Sunil</surname> <given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Role of host-mediated Post-translational modifications (Ptms) in Rna virus pathogenesis</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>:323. doi: <pub-id pub-id-type="doi">10.3390/ijms22010323</pub-id>, PMID: <pub-id pub-id-type="pmid">33396899</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname> <given-names>Y. A.</given-names></name> <name><surname>Hung</surname> <given-names>C. T.</given-names></name> <name><surname>Chien</surname> <given-names>K. Y.</given-names></name> <name><surname>Shih</surname> <given-names>S. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Control of the negative Ires trans-acting factor Khsrp by ubiquitination</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume>, <fpage>271</fpage>&#x2013;<lpage>287</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkw1042</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauwers</surname> <given-names>E.</given-names></name> <name><surname>Jacob</surname> <given-names>C.</given-names></name> <name><surname>Andre</surname> <given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>K63-linked ubiquitin chains as a specific signal for protein sorting into the multivesicular body pathway</article-title>. <source>J. Cell Biol.</source> <volume>185</volume>, <fpage>493</fpage>&#x2013;<lpage>502</lpage>. doi: <pub-id pub-id-type="doi">10.1083/jcb.200810114</pub-id>, PMID: <pub-id pub-id-type="pmid">19398763</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leutert</surname> <given-names>M.</given-names></name> <name><surname>Entwisle</surname> <given-names>S. W.</given-names></name> <name><surname>Villen</surname> <given-names>J.</given-names></name></person-group> (<year>2021</year>). <article-title>Decoding Post-translational modification crosstalk with proteomics</article-title>. <source>Mol. Cell. Proteomics</source> <volume>20</volume>:<fpage>100129</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mcpro.2021.100129</pub-id>, PMID: <pub-id pub-id-type="pmid">34339852</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Huan</surname> <given-names>C.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Su</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Trim21-mediated proteasomal degradation of Samhd1 regulates its antiviral activity</article-title>. <source>EMBO Rep.</source> <volume>21</volume>:<fpage>e47528</fpage>. doi: <pub-id pub-id-type="doi">10.15252/embr.201847528</pub-id>, PMID: <pub-id pub-id-type="pmid">31797533</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>B.</given-names></name> <name><surname>Zhu</surname> <given-names>Y.</given-names></name> <name><surname>Shi</surname> <given-names>W.</given-names></name> <name><surname>Ni</surname> <given-names>C.</given-names></name> <name><surname>Tan</surname> <given-names>B.</given-names></name> <name><surname>Tang</surname> <given-names>S.</given-names></name></person-group> (<year>2023</year>). <article-title>Sars-CoV-2 spike protein Post-translational modification landscape and its impact on protein structure and function via computational prediction</article-title>. <source>Research</source> <volume>6</volume>:<fpage>0078</fpage>. doi: <pub-id pub-id-type="doi">10.34133/research.0078</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Lei</surname> <given-names>X.</given-names></name> <name><surname>Zhou</surname> <given-names>Z.</given-names></name> <name><surname>Sun</surname> <given-names>Z.</given-names></name> <name><surname>Xue</surname> <given-names>Q.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Enterovirus 71 induces degradation of Trim38, a potential E3 ubiquitin ligase</article-title>. <source>Virol. J.</source> <volume>8</volume>:<fpage>61</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1743-422X-8-61</pub-id>, PMID: <pub-id pub-id-type="pmid">21306652</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Song</surname> <given-names>Y.</given-names></name> <name><surname>Xu</surname> <given-names>W.</given-names></name></person-group> (<year>2018</year>). <article-title>Trim21 restricts Coxsackievirus B3 replication, cardiac and pancreatic injury via interacting with Mavs and positively regulating Irf3-mediated type-I interferon production</article-title>. <source>Front. Immunol.</source> <volume>9</volume>:<fpage>2479</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.02479</pub-id>, PMID: <pub-id pub-id-type="pmid">30410495</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Zheng</surname> <given-names>Z.</given-names></name> <name><surname>Shu</surname> <given-names>B.</given-names></name> <name><surname>Meng</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Zheng</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Sumo modification stabilizes enterovirus 71 polymerase 3D to facilitate viral replication</article-title>. <source>J. Virol.</source> <volume>90</volume>, <fpage>10472</fpage>&#x2013;<lpage>10485</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.01756-16</pub-id>, PMID: <pub-id pub-id-type="pmid">27630238</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname> <given-names>J. E.</given-names></name> <name><surname>Sullivan</surname> <given-names>E. D.</given-names></name> <name><surname>Fierke</surname> <given-names>C. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Metal-dependent deacetylases: Cancer and epigenetic regulators</article-title>. <source>ACS Chem. Biol.</source> <volume>11</volume>, <fpage>706</fpage>&#x2013;<lpage>716</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acschembio.5b01067</pub-id>, PMID: <pub-id pub-id-type="pmid">26907466</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Dastvan</surname> <given-names>F.</given-names></name> <name><surname>Yanagawa</surname> <given-names>B.</given-names></name> <name><surname>Reidy</surname> <given-names>M. A.</given-names></name> <name><surname>Zhang</surname> <given-names>H. M.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest</article-title>. <source>J. Virol.</source> <volume>77</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.77.1.1-9.2003</pub-id>, PMID: <pub-id pub-id-type="pmid">12477805</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyoo</surname> <given-names>H.</given-names></name> <name><surname>Dorobantu</surname> <given-names>C. M.</given-names></name> <name><surname>Van Der Schaar</surname> <given-names>H. M.</given-names></name> <name><surname>Van Kuppeveld</surname> <given-names>F. J. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Modulation of proteolytic polyprotein processing by coxsackievirus mutants resistant to inhibitors targeting phosphatidylinositol-4-kinase Iiibeta or oxysterol binding protein</article-title>. <source>Antivir. Res.</source> <volume>147</volume>, <fpage>86</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.10.006</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marchant</surname> <given-names>D.</given-names></name> <name><surname>Dou</surname> <given-names>Y.</given-names></name> <name><surname>Luo</surname> <given-names>H.</given-names></name> <name><surname>Garmaroudi</surname> <given-names>F. S.</given-names></name> <name><surname>Mcdonough</surname> <given-names>J. E.</given-names></name> <name><surname>Si</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditis</article-title>. <source>Circ. Res.</source> <volume>104</volume>, <fpage>813</fpage>&#x2013;<lpage>821</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.191171</pub-id>, PMID: <pub-id pub-id-type="pmid">19213955</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mcphail</surname> <given-names>J. A.</given-names></name> <name><surname>Lyoo</surname> <given-names>H.</given-names></name> <name><surname>Pemberton</surname> <given-names>J. G.</given-names></name> <name><surname>Hoffmann</surname> <given-names>R. M.</given-names></name> <name><surname>Van Elst</surname> <given-names>W.</given-names></name> <name><surname>Strating</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Characterization of the c10orf76-Pi4kb complex and its necessity for Golgi Pi4P levels and enterovirus replication</article-title>. <source>EMBO Rep.</source> <volume>21</volume>:<fpage>e48441</fpage>. doi: <pub-id pub-id-type="doi">10.15252/embr.201948441</pub-id>, PMID: <pub-id pub-id-type="pmid">31829496</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>J.</given-names></name> <name><surname>Yao</surname> <given-names>Z.</given-names></name> <name><surname>He</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>R.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Yao</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Arrdc4 regulates enterovirus 71-induced innate immune response by promoting K63 polyubiquitination of Mda5 through Trim65</article-title>. <source>Cell Death Dis.</source> <volume>8</volume>:<fpage>e2866</fpage>. doi: <pub-id pub-id-type="doi">10.1038/cddis.2017.257</pub-id>, PMID: <pub-id pub-id-type="pmid">28594402</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mirzalieva</surname> <given-names>O.</given-names></name> <name><surname>Juncker</surname> <given-names>M.</given-names></name> <name><surname>Schwartzenburg</surname> <given-names>J.</given-names></name> <name><surname>Desai</surname> <given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Isg15 and Isgylation in human diseases</article-title>. <source>Cell</source> <volume>11</volume>:538. doi: <pub-id pub-id-type="doi">10.3390/cells11030538</pub-id>, PMID: <pub-id pub-id-type="pmid">35159348</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morales-Tarre</surname> <given-names>O.</given-names></name> <name><surname>Alonso-Bastida</surname> <given-names>R.</given-names></name> <name><surname>Arcos-Encarnacion</surname> <given-names>B.</given-names></name> <name><surname>Perez-Martinez</surname> <given-names>L.</given-names></name> <name><surname>Encarnacion-Guevara</surname> <given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Protein lysine acetylation and its role in different human pathologies: a proteomic approach</article-title>. <source>Expert Rev. Proteomics</source> <volume>18</volume>, <fpage>949</fpage>&#x2013;<lpage>975</lpage>. doi: <pub-id pub-id-type="doi">10.1080/14789450.2021.2007766</pub-id>, PMID: <pub-id pub-id-type="pmid">34791964</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>L. A.</given-names></name> <name><surname>Sheng</surname> <given-names>X.</given-names></name> <name><surname>Cristea</surname> <given-names>I. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Orchestration of protein acetylation as a toggle for cellular defense and virus replication</article-title>. <source>Nat. Commun.</source> <volume>9</volume>:<fpage>4967</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-018-07179-w</pub-id>, PMID: <pub-id pub-id-type="pmid">30470744</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>E. S.</given-names></name> <name><surname>Dezhbord</surname> <given-names>M.</given-names></name> <name><surname>Lee</surname> <given-names>A. R.</given-names></name> <name><surname>Kim</surname> <given-names>K. H.</given-names></name></person-group> (<year>2022a</year>). <article-title>The roles of ubiquitination in pathogenesis of influenza virus infection</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume>, 4593. doi: <pub-id pub-id-type="doi">10.3390/ijms23094593</pub-id></citation></ref>
<ref id="ref68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>J. W.</given-names></name> <name><surname>Tyl</surname> <given-names>M. D.</given-names></name> <name><surname>Cristea</surname> <given-names>I. M.</given-names></name></person-group> (<year>2023</year>). <article-title>Orchestration of mitochondrial function and remodeling by Post-translational modifications provide insight into mechanisms of viral infection</article-title>. <source>Biomol. Ther.</source> <volume>13</volume>:869. doi: <pub-id pub-id-type="doi">10.3390/biom13050869</pub-id>, PMID: <pub-id pub-id-type="pmid">37238738</pub-id></citation></ref>
<ref id="ref69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>K.</given-names></name> <name><surname>Zhong</surname> <given-names>J.</given-names></name> <name><surname>Jang</surname> <given-names>J. S.</given-names></name> <name><surname>Kim</surname> <given-names>J.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name> <name><surname>Lee</surname> <given-names>J. H.</given-names></name> <etal/></person-group>. (<year>2022b</year>). <article-title>Zwc complex-mediated Spt5 phosphorylation suppresses divergent antisense Rna transcription at active gene promoters</article-title>. <source>Nucleic Acids Res.</source> <volume>50</volume>, <fpage>3835</fpage>&#x2013;<lpage>3851</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkac193</pub-id>, PMID: <pub-id pub-id-type="pmid">35325203</pub-id></citation></ref>
<ref id="ref70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pellegrino</surname> <given-names>N. E.</given-names></name> <name><surname>Guven</surname> <given-names>A.</given-names></name> <name><surname>Gray</surname> <given-names>K.</given-names></name> <name><surname>Shah</surname> <given-names>P.</given-names></name> <name><surname>Kasture</surname> <given-names>G.</given-names></name> <name><surname>Nastke</surname> <given-names>M. D.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>The next frontier: translational development of ubiquitination, Sumoylation, and Neddylation in Cancer</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume>:3480. doi: <pub-id pub-id-type="doi">10.3390/ijms23073480</pub-id>, PMID: <pub-id pub-id-type="pmid">35408841</pub-id></citation></ref>
<ref id="ref71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puertollano</surname> <given-names>R.</given-names></name> <name><surname>Ferguson</surname> <given-names>S. M.</given-names></name> <name><surname>Brugarolas</surname> <given-names>J.</given-names></name> <name><surname>Ballabio</surname> <given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>The complex relationship between Tfeb transcription factor phosphorylation and subcellular localization</article-title>. <source>EMBO J.</source> <volume>37</volume>. doi: <pub-id pub-id-type="doi">10.15252/embj.201798804</pub-id>, PMID: <pub-id pub-id-type="pmid">29764979</pub-id></citation></ref>
<ref id="ref72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname> <given-names>Y.</given-names></name> <name><surname>Ye</surname> <given-names>X.</given-names></name> <name><surname>Hanson</surname> <given-names>P. J.</given-names></name> <name><surname>Zhang</surname> <given-names>H. M.</given-names></name> <name><surname>Zong</surname> <given-names>J.</given-names></name> <name><surname>Cho</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Hsp70-1: upregulation via selective phosphorylation of heat shock factor 1 during coxsackieviral infection and promotion of viral replication via the au-rich element</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>73</volume>, <fpage>1067</fpage>&#x2013;<lpage>1084</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00018-015-2036-6</pub-id></citation></ref>
<ref id="ref73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rape</surname> <given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Ubiquitylation at the crossroads of development and disease</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>19</volume>, <fpage>59</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrm.2017.83</pub-id>, PMID: <pub-id pub-id-type="pmid">28928488</pub-id></citation></ref>
<ref id="ref74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reineke</surname> <given-names>L. C.</given-names></name> <name><surname>Lloyd</surname> <given-names>R. E.</given-names></name></person-group> (<year>2015</year>). <article-title>The stress granule protein G3bp1 recruits protein kinase R to promote multiple innate immune antiviral responses</article-title>. <source>J. Virol.</source> <volume>89</volume>, <fpage>2575</fpage>&#x2013;<lpage>2589</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.02791-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25520508</pub-id></citation></ref>
<ref id="ref75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saguil</surname> <given-names>A.</given-names></name> <name><surname>Kane</surname> <given-names>S. F.</given-names></name> <name><surname>Lauters</surname> <given-names>R.</given-names></name> <name><surname>Mercado</surname> <given-names>M. G.</given-names></name></person-group> (<year>2019</year>). <article-title>Hand-foot-and-mouth disease: rapid evidence review</article-title>. <source>Am. Fam. Physician</source> <volume>100</volume>, <fpage>408</fpage>&#x2013;<lpage>414</lpage>. PMID: <pub-id pub-id-type="pmid">31573162</pub-id></citation></ref>
<ref id="ref76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schweppe</surname> <given-names>R. E.</given-names></name> <name><surname>Haydon</surname> <given-names>C. E.</given-names></name> <name><surname>Lewis</surname> <given-names>T. S.</given-names></name> <name><surname>Resing</surname> <given-names>K. A.</given-names></name> <name><surname>Ahn</surname> <given-names>N. G.</given-names></name></person-group> (<year>2003</year>). <article-title>The characterization of protein post-translational modifications by mass spectrometry</article-title>. <source>Acc. Chem. Res.</source> <volume>36</volume>, <fpage>453</fpage>&#x2013;<lpage>461</lpage>. doi: <pub-id pub-id-type="doi">10.1021/ar020143l</pub-id></citation></ref>
<ref id="ref77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname> <given-names>S. H.</given-names></name> <name><surname>Park</surname> <given-names>J. H.</given-names></name> <name><surname>Ye</surname> <given-names>M. B.</given-names></name> <name><surname>Nam</surname> <given-names>J. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Histone deacetylase inhibitors suppress coxsackievirus B3 growth in vitro and myocarditis induced in mice</article-title>. <source>Acta Virol.</source> <volume>57</volume>, <fpage>462</fpage>&#x2013;<lpage>466</lpage>. doi: <pub-id pub-id-type="doi">10.4149/av_2013_04_462</pub-id>, PMID: <pub-id pub-id-type="pmid">24294962</pub-id></citation></ref>
<ref id="ref78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shishova</surname> <given-names>A.</given-names></name> <name><surname>Dyugay</surname> <given-names>I.</given-names></name> <name><surname>Fominykh</surname> <given-names>K.</given-names></name> <name><surname>Baryshnikova</surname> <given-names>V.</given-names></name> <name><surname>Dereventsova</surname> <given-names>A.</given-names></name> <name><surname>Turchenko</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Enteroviruses manipulate the unfolded protein response through multifaceted deregulation of the Ire1-Xbp1 pathway</article-title>. <source>Viruses</source> <volume>14</volume>:2486. doi: <pub-id pub-id-type="doi">10.3390/v14112486</pub-id>, PMID: <pub-id pub-id-type="pmid">36366584</pub-id></citation></ref>
<ref id="ref79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Si</surname> <given-names>X.</given-names></name> <name><surname>Gao</surname> <given-names>G.</given-names></name> <name><surname>Wong</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Luo</surname> <given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Ubiquitination is required for effective replication of coxsackievirus B3</article-title>. <source>PLoS One</source> <volume>3</volume>:<fpage>e2585</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0002585</pub-id>, PMID: <pub-id pub-id-type="pmid">18612413</pub-id></citation></ref>
<ref id="ref80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Si</surname> <given-names>X.</given-names></name> <name><surname>Luo</surname> <given-names>H.</given-names></name> <name><surname>Morgan</surname> <given-names>A.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Wong</surname> <given-names>J.</given-names></name> <name><surname>Yuan</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2005a</year>). <article-title>Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release</article-title>. <source>J. Virol.</source> <volume>79</volume>, <fpage>13875</fpage>&#x2013;<lpage>13881</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.79.22.13875-13881.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">16254323</pub-id></citation></ref>
<ref id="ref81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Si</surname> <given-names>X.</given-names></name> <name><surname>Mcmanus</surname> <given-names>B. M.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Yuan</surname> <given-names>J.</given-names></name> <name><surname>Cheung</surname> <given-names>C.</given-names></name> <name><surname>Esfandiarei</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2005b</year>). <article-title>Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway</article-title>. <source>J. Virol.</source> <volume>79</volume>, <fpage>8014</fpage>&#x2013;<lpage>8023</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.79.13.8014-8023.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">15956547</pub-id></citation></ref>
<ref id="ref82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Si</surname> <given-names>X.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Wong</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Mcmanus</surname> <given-names>B. M.</given-names></name> <name><surname>Luo</surname> <given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication</article-title>. <source>J. Virol.</source> <volume>81</volume>, <fpage>3142</fpage>&#x2013;<lpage>3150</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.02028-06</pub-id>, PMID: <pub-id pub-id-type="pmid">17229707</pub-id></citation></ref>
<ref id="ref83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>B. J.</given-names></name> <name><surname>Carregari</surname> <given-names>V. C.</given-names></name></person-group> (<year>2022</year>). <article-title>Histone modifications in neurological disorders</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>1382</volume>, <fpage>95</fpage>&#x2013;<lpage>107</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-3-031-05460-0_7</pub-id></citation></ref>
<ref id="ref84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>J. H.</given-names></name> <name><surname>Ahn</surname> <given-names>J. H.</given-names></name> <name><surname>Kim</surname> <given-names>S. R.</given-names></name> <name><surname>Cho</surname> <given-names>S.</given-names></name> <name><surname>Hong</surname> <given-names>E. H.</given-names></name> <name><surname>Kwon</surname> <given-names>B. E.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the Sting/Tbk-1/Irf3 signalling pathway</article-title>. <source>Sci. Rep.</source> <volume>9</volume>:<fpage>9413</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-019-45868-8</pub-id></citation></ref>
<ref id="ref85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>B.</given-names></name> <name><surname>Liu</surname> <given-names>D.</given-names></name> <name><surname>Greco</surname> <given-names>T. M.</given-names></name> <name><surname>Cristea</surname> <given-names>I. M.</given-names></name></person-group> (<year>2021</year>). <article-title>Post-translational modification control of viral Dna sensors and innate immune signaling</article-title>. <source>Adv. Virus Res.</source> <volume>109</volume>, <fpage>163</fpage>&#x2013;<lpage>199</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.aivir.2021.03.001</pub-id>, PMID: <pub-id pub-id-type="pmid">33934827</pub-id></citation></ref>
<ref id="ref86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>C. F.</given-names></name> <name><surname>Li</surname> <given-names>Y. Q.</given-names></name> <name><surname>Mao</surname> <given-names>X. M.</given-names></name></person-group> (<year>2020</year>). <article-title>Regulation of protein Post-translational modifications on metabolism of Actinomycetes</article-title>. <source>Biomol. Ther.</source> <volume>10</volume>:1122. doi: <pub-id pub-id-type="doi">10.3390/biom10081122</pub-id>, PMID: <pub-id pub-id-type="pmid">32751230</pub-id></citation></ref>
<ref id="ref87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swatek</surname> <given-names>K. N.</given-names></name> <name><surname>Komander</surname> <given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Ubiquitin modifications</article-title>. <source>Cell Res.</source> <volume>26</volume>, <fpage>399</fpage>&#x2013;<lpage>422</lpage>. doi: <pub-id pub-id-type="doi">10.1038/cr.2016.39</pub-id>, PMID: <pub-id pub-id-type="pmid">27012465</pub-id></citation></ref>
<ref id="ref88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tabor-Godwin</surname> <given-names>J. M.</given-names></name> <name><surname>Tsueng</surname> <given-names>G.</given-names></name> <name><surname>Sayen</surname> <given-names>M. R.</given-names></name> <name><surname>Gottlieb</surname> <given-names>R. A.</given-names></name> <name><surname>Feuer</surname> <given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>The role of autophagy during coxsackievirus infection of neural progenitor and stem cells</article-title>. <source>Autophagy</source> <volume>8</volume>, <fpage>938</fpage>&#x2013;<lpage>953</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.19781</pub-id>, PMID: <pub-id pub-id-type="pmid">22751470</pub-id></citation></ref>
<ref id="ref89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsikas</surname> <given-names>D.</given-names></name></person-group> (<year>2021</year>). <article-title>Post-translational modifications (Ptm): analytical approaches, signaling, physiology and pathophysiology-part I</article-title>. <source>Amino Acids</source> <volume>53</volume>, <fpage>485</fpage>&#x2013;<lpage>487</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00726-021-02984-y</pub-id>, PMID: <pub-id pub-id-type="pmid">33929637</pub-id></citation></ref>
<ref id="ref90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turkki</surname> <given-names>P.</given-names></name> <name><surname>Makkonen</surname> <given-names>K. E.</given-names></name> <name><surname>Huttunen</surname> <given-names>M.</given-names></name> <name><surname>Laakkonen</surname> <given-names>J. P.</given-names></name> <name><surname>Yla-Herttuala</surname> <given-names>S.</given-names></name> <name><surname>Airenne</surname> <given-names>K. J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Cell susceptibility to baculovirus transduction and echovirus infection is modified by protein kinase C phosphorylation and vimentin organization</article-title>. <source>J. Virol.</source> <volume>87</volume>, <fpage>9822</fpage>&#x2013;<lpage>9835</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.01004-13</pub-id>, PMID: <pub-id pub-id-type="pmid">23824807</pub-id></citation></ref>
<ref id="ref91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Wijk</surname> <given-names>S. J.</given-names></name> <name><surname>Fulda</surname> <given-names>S.</given-names></name> <name><surname>Dikic</surname> <given-names>I.</given-names></name> <name><surname>Heilemann</surname> <given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Visualizing ubiquitination in mammalian cells</article-title>. <source>EMBO Rep.</source> <volume>20</volume>. doi: <pub-id pub-id-type="doi">10.15252/embr.201846520</pub-id></citation></ref>
<ref id="ref92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verdin</surname> <given-names>E.</given-names></name> <name><surname>Ott</surname> <given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>16</volume>, <fpage>258</fpage>&#x2013;<lpage>264</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrm3931</pub-id>, PMID: <pub-id pub-id-type="pmid">25549891</pub-id></citation></ref>
<ref id="ref93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Voss</surname> <given-names>M.</given-names></name> <name><surname>Braun</surname> <given-names>V.</given-names></name> <name><surname>Bredow</surname> <given-names>C.</given-names></name> <name><surname>Kloetzel</surname> <given-names>P. M.</given-names></name> <name><surname>Beling</surname> <given-names>A.</given-names></name></person-group> (<year>2021</year>). <article-title>Coxsackievirus B3 exploits the ubiquitin-proteasome system to facilitate viral replication</article-title>. <source>Viruses</source> <volume>13</volume>:1360. doi: <pub-id pub-id-type="doi">10.3390/v13071360</pub-id>, PMID: <pub-id pub-id-type="pmid">34372566</pub-id></citation></ref>
<ref id="ref94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vu</surname> <given-names>L. D.</given-names></name> <name><surname>Gevaert</surname> <given-names>K.</given-names></name> <name><surname>De Smet</surname> <given-names>I.</given-names></name></person-group> (<year>2018</year>). <article-title>Protein language: Post-translational modifications talking to each other</article-title>. <source>Trends Plant Sci.</source> <volume>23</volume>, <fpage>1068</fpage>&#x2013;<lpage>1080</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tplants.2018.09.004</pub-id>, PMID: <pub-id pub-id-type="pmid">30279071</pub-id></citation></ref>
<ref id="ref95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Yuan</surname> <given-names>M.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Zhang</surname> <given-names>R.</given-names></name> <name><surname>Zou</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Stat3 regulates the type I Ifn-mediated antiviral response by interfering with the nuclear entry of Stat1</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume>:4870. doi: <pub-id pub-id-type="doi">10.3390/ijms20194870</pub-id></citation></ref>
<ref id="ref96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Zhong</surname> <given-names>M.</given-names></name> <name><surname>Cui</surname> <given-names>B.</given-names></name> <name><surname>Yan</surname> <given-names>H.</given-names></name> <name><surname>Wu</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Neddylation of enterovirus 71 Vp2 protein reduces its stability and restricts viral replication</article-title>. <source>J. Virol.</source> <volume>96</volume>:<fpage>e0059822</fpage>. doi: <pub-id pub-id-type="doi">10.1128/jvi.00598-22</pub-id>, PMID: <pub-id pub-id-type="pmid">35510863</pub-id></citation></ref>
<ref id="ref97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>B.</given-names></name> <name><surname>Lu</surname> <given-names>F.</given-names></name> <name><surname>Kong</surname> <given-names>Q.</given-names></name> <name><surname>Huang</surname> <given-names>Y.</given-names></name> <name><surname>Huang</surname> <given-names>K.</given-names></name> <name><surname>Wu</surname> <given-names>W.</given-names></name></person-group> (<year>2022</year>). <article-title>Trehalose induces B cell autophagy to alleviate myocardial injury via the Ampk/Ulk1 signalling pathway in acute viral myocarditis induced by Coxsackie virus B3</article-title>. <source>Int. J. Biochem. Cell Biol.</source> <volume>146</volume>:<fpage>106208</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biocel.2022.106208</pub-id>, PMID: <pub-id pub-id-type="pmid">35381374</pub-id></citation></ref>
<ref id="ref98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>W. R.</given-names></name> <name><surname>Chen</surname> <given-names>Y. Y.</given-names></name> <name><surname>Yang</surname> <given-names>S. M.</given-names></name> <name><surname>Chen</surname> <given-names>Y. L.</given-names></name> <name><surname>Horng</surname> <given-names>J. T.</given-names></name></person-group> (<year>2005</year>). <article-title>Phosphorylation of Pi3K/Akt and Mapk/Erk in an early entry step of enterovirus 71</article-title>. <source>Life Sci.</source> <volume>78</volume>, <fpage>82</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lfs.2005.04.076</pub-id>, PMID: <pub-id pub-id-type="pmid">16150462</pub-id></citation></ref>
<ref id="ref99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>K. X.</given-names></name> <name><surname>Chu</surname> <given-names>J. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Antiviral screen identifies Ev71 inhibitors and reveals camptothecin-target, Dna topoisomerase 1 as a novel Ev71 host factor</article-title>. <source>Antivir. Res.</source> <volume>143</volume>, <fpage>122</fpage>&#x2013;<lpage>133</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.04.008</pub-id>, PMID: <pub-id pub-id-type="pmid">28427827</pub-id></citation></ref>
<ref id="ref100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Yang</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Rui</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Ectopic expression of Trim25 restores rig-I expression and Ifn production reduced by multiple enteroviruses 3C (pro)</article-title>. <source>Virol. Sin.</source> <volume>36</volume>, <fpage>1363</fpage>&#x2013;<lpage>1374</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12250-021-00410-x</pub-id>, PMID: <pub-id pub-id-type="pmid">34170466</pub-id></citation></ref>
<ref id="ref101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>C.</given-names></name> <name><surname>Peng</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Q.</given-names></name> <name><surname>Xu</surname> <given-names>X. P.</given-names></name> <name><surname>Kong</surname> <given-names>X. M.</given-names></name> <name><surname>Shi</surname> <given-names>W. F.</given-names></name></person-group> (<year>2018</year>). <article-title>Usp4 positively regulates Rlr-induced Nf-kappaB activation by targeting Traf6 for K48-linked deubiquitination and inhibits enterovirus 71 replication</article-title>. <source>Sci. Rep.</source> <volume>8</volume>:<fpage>13418</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-018-31734-6</pub-id>, PMID: <pub-id pub-id-type="pmid">30194441</pub-id></citation></ref>
<ref id="ref102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname> <given-names>M.</given-names></name> <name><surname>Feng</surname> <given-names>T.</given-names></name> <name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Yan</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Dai</surname> <given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Protein acetylation going viral: implications in antiviral immunity and viral infection</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume>:11308. doi: <pub-id pub-id-type="doi">10.3390/ijms231911308</pub-id>, PMID: <pub-id pub-id-type="pmid">36232610</pub-id></citation></ref>
<ref id="ref103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname> <given-names>A.</given-names></name> <name><surname>Jin</surname> <given-names>Y.</given-names></name> <name><surname>Ohsumi</surname> <given-names>Y.</given-names></name></person-group> (<year>2020</year>). <article-title>Mitotic phosphorylation of the Ulk complex regulates cell cycle progression</article-title>. <source>PLoS Biol.</source> <volume>18</volume>:<fpage>e3000718</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pbio.3000718</pub-id>, PMID: <pub-id pub-id-type="pmid">32516305</pub-id></citation></ref>
<ref id="ref104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>X.</given-names></name> <name><surname>Zhang</surname> <given-names>H. M.</given-names></name> <name><surname>Qiu</surname> <given-names>Y.</given-names></name> <name><surname>Hanson</surname> <given-names>P. J.</given-names></name> <name><surname>Hemida</surname> <given-names>M. G.</given-names></name> <name><surname>Wei</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components</article-title>. <source>PLoS Pathog.</source> <volume>10</volume>:<fpage>e1004070</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1004070</pub-id>, PMID: <pub-id pub-id-type="pmid">24722419</pub-id></citation></ref>
<ref id="ref105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>J.</given-names></name> <name><surname>Dai</surname> <given-names>Y.</given-names></name> <name><surname>Fu</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>K.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Cathelicidin antimicrobial peptides suppress Ev71 infection via regulating antiviral response and inhibiting viral binding</article-title>. <source>Antivir. Res.</source> <volume>187</volume>:<fpage>105021</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.antiviral.2021.105021</pub-id>, PMID: <pub-id pub-id-type="pmid">33508330</pub-id></citation></ref>
<ref id="ref106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Cong</surname> <given-names>H.</given-names></name> <name><surname>Song</surname> <given-names>L.</given-names></name> <name><surname>Tien</surname> <given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>The nuclear protein Sam68 is redistributed to the cytoplasm and is involved in Pi3K/Akt activation during Ev71 infection</article-title>. <source>Virus Res.</source> <volume>180</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virusres.2013.11.020</pub-id></citation></ref>
<ref id="ref107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Tang</surname> <given-names>B.</given-names></name> <name><surname>Zhang</surname> <given-names>C. Y.</given-names></name></person-group> (<year>2017</year>). <article-title>The strategies for identification and quantification of Sumoylation</article-title>. <source>Chem. Commun. (Camb.)</source> <volume>53</volume>, <fpage>6989</fpage>&#x2013;<lpage>6998</lpage>. doi: <pub-id pub-id-type="doi">10.1039/C7CC00901A</pub-id>, PMID: <pub-id pub-id-type="pmid">28589199</pub-id></citation></ref>
<ref id="ref108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>F.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Dong</surname> <given-names>L.</given-names></name> <name><surname>Zhou</surname> <given-names>B.</given-names></name> <name><surname>Cheng</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Rassf4 promotes Ev71 replication to accelerate the inhibition of the phosphorylation of Akt</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>458</volume>, <fpage>810</fpage>&#x2013;<lpage>815</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2015.02.035</pub-id>, PMID: <pub-id pub-id-type="pmid">25701784</pub-id></citation></ref>
<ref id="ref109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Pelech</surname> <given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Using protein microarrays to study phosphorylation-mediated signal transduction</article-title>. <source>Semin. Cell Dev. Biol.</source> <volume>23</volume>, <fpage>872</fpage>&#x2013;<lpage>882</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.semcdb.2012.05.009</pub-id>, PMID: <pub-id pub-id-type="pmid">22706299</pub-id></citation></ref>
<ref id="ref110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H. M.</given-names></name> <name><surname>Wang</surname> <given-names>F.</given-names></name> <name><surname>Qiu</surname> <given-names>Y.</given-names></name> <name><surname>Ye</surname> <given-names>X.</given-names></name> <name><surname>Hanson</surname> <given-names>P.</given-names></name> <name><surname>Shen</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation</article-title>. <source>Biochem. J.</source> <volume>473</volume>, <fpage>473</fpage>&#x2013;<lpage>485</lpage>. doi: <pub-id pub-id-type="doi">10.1042/BJ20150419</pub-id>, PMID: <pub-id pub-id-type="pmid">26621875</pub-id></citation></ref>
<ref id="ref111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Bie</surname> <given-names>Y.</given-names></name> <name><surname>Kong</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>A.</given-names></name> <name><surname>Qiu</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Stub1 regulates antiviral Rnai through inducing ubiquitination and degradation of dicer and Ago2 in mammals</article-title>. <source>Virol. Sin.</source> <volume>37</volume>, <fpage>569</fpage>&#x2013;<lpage>580</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virs.2022.05.001</pub-id>, PMID: <pub-id pub-id-type="pmid">35533808</pub-id></citation></ref>
<ref id="ref112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>B.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Tumaneng</surname> <given-names>K.</given-names></name> <name><surname>Wang</surname> <given-names>C. Y.</given-names></name> <name><surname>Guan</surname> <given-names>K. L.</given-names></name></person-group> (<year>2010</year>). <article-title>A coordinated phosphorylation by Lats and Ck1 regulates yap stability through Scf (beta-Trcp)</article-title>. <source>Genes Dev.</source> <volume>24</volume>, <fpage>72</fpage>&#x2013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gad.1843810</pub-id>, PMID: <pub-id pub-id-type="pmid">20048001</pub-id></citation></ref>
<ref id="ref113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>X.</given-names></name> <name><surname>Yuan</surname> <given-names>H.</given-names></name> <name><surname>Yang</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Xun</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>N-acetyltransferase 8 promotes viral replication by increasing the stability of enterovirus 71 nonstructural proteins</article-title>. <source>J. Virol.</source> <volume>96</volume>:<fpage>e0011922</fpage>. doi: <pub-id pub-id-type="doi">10.1128/jvi.00119-22</pub-id>, PMID: <pub-id pub-id-type="pmid">35170979</pub-id></citation></ref>
<ref id="ref114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>Z.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>Z.</given-names></name> <name><surname>Meng</surname> <given-names>J.</given-names></name> <name><surname>Mao</surname> <given-names>D.</given-names></name> <name><surname>Bai</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Enterovirus 71 2C protein inhibits Tnf-alpha-mediated activation of Nf-kappaB by suppressing IkappaB kinase beta phosphorylation</article-title>. <source>J. Immunol.</source> <volume>187</volume>, <fpage>2202</fpage>&#x2013;<lpage>2212</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1100285</pub-id>, PMID: <pub-id pub-id-type="pmid">21810613</pub-id></citation></ref>
<ref id="ref115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>L.</given-names></name> <name><surname>He</surname> <given-names>X.</given-names></name> <name><surname>Gao</surname> <given-names>B.</given-names></name> <name><surname>Xiong</surname> <given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Inhibition of histone deacetylase activity aggravates Coxsackievirus B3-induced myocarditis by promoting viral replication and myocardial apoptosis</article-title>. <source>J. Virol.</source> <volume>89</volume>, <fpage>10512</fpage>&#x2013;<lpage>10523</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.01028-15</pub-id>, PMID: <pub-id pub-id-type="pmid">26269170</pub-id></citation></ref>
<ref id="ref116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>G.</given-names></name> <name><surname>Jin</surname> <given-names>L.</given-names></name> <name><surname>Sun</surname> <given-names>W.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Liu</surname> <given-names>N.</given-names></name></person-group> (<year>2022b</year>). <article-title>Proteomics of post-translational modifications in colorectal cancer: discovery of new biomarkers</article-title>. <source>Biochim. Biophys. Acta Rev. Cancer</source> <volume>1877</volume>:<fpage>188735</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbcan.2022.188735</pub-id>, PMID: <pub-id pub-id-type="pmid">35577141</pub-id></citation></ref>
<ref id="ref117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>Q.</given-names></name> <name><surname>Liang</surname> <given-names>P.</given-names></name> <name><surname>Chu</surname> <given-names>C.</given-names></name> <name><surname>Zhang</surname> <given-names>A.</given-names></name> <name><surname>Zhou</surname> <given-names>W.</given-names></name></person-group> (<year>2022c</year>). <article-title>Protein sumoylation in normal and cancer stem cells</article-title>. <source>Front. Mol. Biosci.</source> <volume>9</volume>:<fpage>1095142</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmolb.2022.1095142</pub-id>, PMID: <pub-id pub-id-type="pmid">36601585</pub-id></citation></ref>
<ref id="ref118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>F.</given-names></name> <name><surname>Yang</surname> <given-names>S.</given-names></name> <name><surname>Meng</surname> <given-names>F.</given-names></name> <name><surname>Zheng</surname> <given-names>Y.</given-names></name> <name><surname>Ku</surname> <given-names>X.</given-names></name> <name><surname>Luo</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2022a</year>). <article-title>Leveraging protein dynamics to identify functional phosphorylation sites using deep learning models</article-title>. <source>J. Chem. Inf. Model.</source> <volume>62</volume>, <fpage>3331</fpage>&#x2013;<lpage>3345</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.jcim.2c00484</pub-id>, PMID: <pub-id pub-id-type="pmid">35816597</pub-id></citation></ref>
<ref id="ref119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zolg</surname> <given-names>D. P.</given-names></name> <name><surname>Wilhelm</surname> <given-names>M.</given-names></name> <name><surname>Schmidt</surname> <given-names>T.</given-names></name> <name><surname>Medard</surname> <given-names>G.</given-names></name> <name><surname>Zerweck</surname> <given-names>J.</given-names></name> <name><surname>Knaute</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>ProteomeTools: systematic characterization of 21 Post-translational protein modifications by liquid chromatography tandem mass spectrometry (Lc-Ms/Ms) using synthetic peptides</article-title>. <source>Mol. Cell. Proteomics</source> <volume>17</volume>, <fpage>1850</fpage>&#x2013;<lpage>1863</lpage>. doi: <pub-id pub-id-type="doi">10.1074/mcp.TIR118.000783</pub-id>, PMID: <pub-id pub-id-type="pmid">29848782</pub-id></citation></ref>
</ref-list>
</back>
</article>